Tuesday 01/4/2022

E-Mail Message

From: Вам выдан разовый доступ на регистрацию в уникальной инновационной платформе с потенциальным доходом до 3000y.e в сутки. Подробности www.tinyurl.com/y2ak6aqs
Email: [email protected]

Message:

DjcTJAH GHJA LoGQfJO ToKcW3w uVMm tNpuAa9

.

Attn: Kelly Day

Greetings to you and your family, I've received and read your mail and
as a human rights protester in connection with a member of the
Compensation Award Committee, currently in Oklahoma It is a great
pleasure to know that Ms.Gertie Jenkins and other victims around the
globe has made mentioned of my good performance regarding the
outstanding payment here and I must make it clear to you that with
your maximum compliance in this, you will as well receive your total
inheritance fund within three Bank working days without any hitches or
hindrance as Ms.Gertie Jenkins and others.

I have done this successfully for over two years now and the
attestation of people like Ms.Gertie Jenkins is a pointer to the good
work I have done to the satisfaction of our numerous clients who have
been relieved of the nefarious and corrupt activities of several
government officials who are hell bent on frustrating the efforts of
genuine beneficiaries/claimants.

So after going through your payment files, I've come to understand the
inconveniences and financial commitments you have invested so far for
the pursuit of this fund which was all to no avail.However,considering
your efforts towards achieving this aim,we have come to maintain
equity,justice and fairness in our dealings with beneficiaries such as
yours, hence we have insisted that your funds should be reversed from
the government treasury account and be released to you accordingly.

However,due to humanitarian ground and sympathy and because I do not
want your payment cancelled so I immediately called up the
International Monetary Fund (IMF)Director" Mrs.Kristalina Georgieva to
explain your matter to her as in regards to your payment and She
personally called up a meeting which was resolved that all payments
charges and any payment fees must be reduced to it's barest menial in
order to enable you afford to pay the fee so that your payment will be
released to you within three Bank working days. To this end it will
interest you to know that every and any fee/charges required of you
have been reduced to only the sum of $300.00 USD,this step is in order
to enable you have this only fee paid so that your Release Approval
Certificate and Legal Affidavit for support are procured and acquired
in other to enable the speedy accelerated transfer/delivery of your
$7,500,000.00 USD into any bank account of your choice.

Please I want you to know that you have within 72hours to effect the
required payment so we can clear/release and effect the
transfer/delivery of your fund worth $7,500,000.00 USD in our care to
any bank account of your choice, so I urge you to send the $300.00 USD
through USPS OverNight Priority Mail, MONEY GRAM, WALMART to WALMART,
with the information that will be supply to you in my next email
message after I have heard back from you.

I want you to know that I am indeed very sorry for any inconveniences
or any delay this must have caused you in having your fund paid out to
you long before now. You will never ever regret paying the fee, this
is a promise to you after all your pains in the past as I am here to
give you my best service as my word is my bond always.Finally,I want
to use this opportunity to assure and guarantee to give you the best
of my performance and after the transaction you will have enough
reason to smile and make a good recommendation of my honesty just like
Ms.Gertie Jenkins and others. Note: You have only two methods to
receive this overdue payment, 1 is by Bank to Bank wire transfer, 2 is
by crediting the funds into an ATM CARD and have it mail to your home
address. The address info to send the only fee of $300.00 USD will be
provided to you as soon as I heard back from you. I await your timely
response. Thanks and remain blessed.

Warmest regards
Mr. Edward David
Text or Call: 202-539-8959,immediately after reading this mail Its
very urgent and important,
Please acknowledge receipt.

---------------------------------------------------------------------------=
------------------------

Hello,
can you give me an example of this? I would like to know roughly what
it looks like.

Kelly Day
CEO, MNesty, LLC

On 23/08/2022 21:43 PM, wrote:
> UPDATE ABOUT YOUR COMPENSATION FUNDS
> Note: if you found this email in your junk/spam, it's because of yourinte=
rnet ISP server.
> I am Ms. Gertie Jenkins, I am a US citizen, 58 years Old. I am one of tho=
se people that took part in receiving Inheritance funds in East & West Afri=
ca many years ago and they refused to pay me, I had paid different fees whi=
le in the United States trying to get my funds from those banks and lottery=
organizers but all to no avail.
> So I decided to travel to Wright City, Oklahoma with all my compensation =
documents, And I was directed by the Federal Bureau ofInvestigation Directo=
r to contact Mr. Edward J.DAVID, who is a representative of the INTERNATION=
AL MONETARY FUND (IMF),a Human Rights Activist and a member of the Compensa=
tion Award Committee, currently in Wright City, Oklahoma and I contacted hi=
m and he explained everything to me. He said whoever is contacting us throu=
gh emails are fake, Mr. Edward J.DAVID personally directed me on how to cla=
im my Inheritance fund.
> He directed me to the paying bank for the claim of my Compensation paymen=
t. Right now I am the happiest woman on earth because I have received my co=
mpensation funds amounting to $7,500,000.00. Moreover, Mr.Edward J.DAVID sh=
owed me the full information of those that are yet to receive their payment=
s and those whose inheritance had not been paid and the list of all outstan=
ding contractor that were owed that are yet to receive their payments and I=
saw your email as one of the beneficiaries on the list he showed me, that =
is why I decided to email you to stop dealing with those people, they are n=
ot with your funds, they are only making money out of you. I will advise yo=
u to contact Mr.Edward J.DAVID. Kindly send your personal details to him to=
prove your identification such as below:
> Full names:....Home address:....Current Phone No:....Country:............=
..
> You have to contact him directly on this information below.
> Compensation Award Office.Name : Mr.Edward J.DAVIDEmail: edwarddavid0460@=
gmail.com
> You really have to stop dealing with those people that are contacting you=
and telling you that your fund is with them, it is not in anyway with them=
, they are only taking advantage of you and they will dry you up until you =
have nothing left.The only money I paid after I met Mr.Edward J.DAVID was f=
or full legal affidavit to support my claim and approval of my compensation=
funds release which will enable the transfer of the funds immediately to y=
our bank account or whichever way you desire to receive your payment.Take n=
ote of that and i will advise you to contact him Asap if you wish to receiv=
e your fund without any furtherwasting of time.
> Thank You and Be Blessed.
> Ms.Gertie Jenkins.

.

Attn: Kelly Day

Greetings to you and your family, I've received and read your mail and
as a human rights protester in connection with a member of the
Compensation Award Committee, currently in Oklahoma It is a great
pleasure to know that Ms.Gertie Jenkins and other victims around the
globe has made mentioned of my good performance regarding the
outstanding payment here and I must make it clear to you that with
your maximum compliance in this, you will as well receive your total
inheritance fund within three Bank working days without any hitches or
hindrance as Ms.Gertie Jenkins and others.

I have done this successfully for over two years now and the
attestation of people like Ms.Gertie Jenkins is a pointer to the good
work I have done to the satisfaction of our numerous clients who have
been relieved of the nefarious and corrupt activities of several
government officials who are hell bent on frustrating the efforts of
genuine beneficiaries/claimants.

So after going through your payment files, I've come to understand the
inconveniences and financial commitments you have invested so far for
the pursuit of this fund which was all to no avail.However,considering
your efforts towards achieving this aim,we have come to maintain
equity,justice and fairness in our dealings with beneficiaries such as
yours, hence we have insisted that your funds should be reversed from
the government treasury account and be released to you accordingly.

However,due to humanitarian ground and sympathy and because I do not
want your payment cancelled so I immediately called up the
International Monetary Fund (IMF)Director" Mrs.Kristalina Georgieva to
explain your matter to her as in regards to your payment and She
personally called up a meeting which was resolved that all payments
charges and any payment fees must be reduced to it's barest menial in
order to enable you afford to pay the fee so that your payment will be
released to you within three Bank working days. To this end it will
interest you to know that every and any fee/charges required of you
have been reduced to only the sum of $300.00 USD,this step is in order
to enable you have this only fee paid so that your Release Approval
Certificate and Legal Affidavit for support are procured and acquired
in other to enable the speedy accelerated transfer/delivery of your
$7,500,000.00 USD into any bank account of your choice.

Please I want you to know that you have within 72hours to effect the
required payment so we can clear/release and effect the
transfer/delivery of your fund worth $7,500,000.00 USD in our care to
any bank account of your choice, so I urge you to send the $300.00 USD
through USPS OverNight Priority Mail, MONEY GRAM, WALMART to WALMART,
with the information that will be supply to you in my next email
message after I have heard back from you.

I want you to know that I am indeed very sorry for any inconveniences
or any delay this must have caused you in having your fund paid out to
you long before now. You will never ever regret paying the fee, this
is a promise to you after all your pains in the past as I am here to
give you my best service as my word is my bond always.Finally,I want
to use this opportunity to assure and guarantee to give you the best
of my performance and after the transaction you will have enough
reason to smile and make a good recommendation of my honesty just like
Ms.Gertie Jenkins and others. Note: You have only two methods to
receive this overdue payment, 1 is by Bank to Bank wire transfer, 2 is
by crediting the funds into an ATM CARD and have it mail to your home
address. The address info to send the only fee of $300.00 USD will be
provided to you as soon as I heard back from you. I await your timely
response. Thanks and remain blessed.

Warmest regards
Mr. Edward David
Text or Call: 202-539-8959,immediately after reading this mail Its
very urgent and important,
Please acknowledge receipt.

On 8/23/22, Kelly Day <[email protected]> wrote:
> Hello,
> can you give me an example of this? I would like to know roughly what it
> looks like.
>
> Kelly Day
> CEO, MNesty, LLC
>
> On 23/08/2022 21:43 PM, wrote:
>> UPDATE ABOUT YOUR COMPENSATION FUNDS
>> Note: if you found this email in your junk/spam, it's because of
>> yourinternet ISP server.
>> I am Ms. Gertie Jenkins, I am a US citizen, 58 years Old. I am one of
>> those people that took part in receiving Inheritance funds in East & West
>> Africa many years ago and they refused to pay me, I had paid different
>> fees while in the United States trying to get my funds from those banks
>> and lottery organizers but all to no avail.
>> So I decided to travel to Wright City, Oklahoma with all my compensation
>> documents, And I was directed by the Federal Bureau ofInvestigation
>> Director to contact Mr. Edward J.DAVID, who is a representative of the
>> INTERNATIONAL MONETARY FUND (IMF),a Human Rights Activist and a member of
>> the Compensation Award Committee, currently in Wright City, Oklahoma and I
>> contacted him and he explained everything to me. He said whoever is
>> contacting us through emails are fake, Mr. Edward J.DAVID personally
>> directed me on how to claim my Inheritance fund.
>> He directed me to the paying bank for the claim of my Compensation
>> payment. Right now I am the happiest woman on earth because I have
>> received my compensation funds amounting to $7,500,000.00. Moreover,
>> Mr.Edward J.DAVID showed me the full information of those that are yet to
>> receive their payments and those whose inheritance had not been paid and
>> the list of all outstanding contractor that were owed that are yet to
>> receive their payments and I saw your email as one of the beneficiaries on
>> the list he showed me, that is why I decided to email you to stop dealing
>> with those people, they are not with your funds, they are only making
>> money out of you. I will advise you to contact Mr.Edward J.DAVID. Kindly
>> send your personal details to him to prove your identification such as
>> below:
>> Full names:....Home address:....Current Phone
>> No:....Country:..............
>> You have to contact him directly on this information below.
>> Compensation Award Office.Name : Mr.Edward J.DAVIDEmail:
>> [email protected]
>> You really have to stop dealing with those people that are contacting you
>> and telling you that your fund is with them, it is not in anyway with
>> them, they are only taking advantage of you and they will dry you up until
>> you have nothing left.The only money I paid after I met Mr.Edward J.DAVID
>> was for full legal affidavit to support my claim and approval of my
>> compensation funds release which will enable the transfer of the funds
>> immediately to your bank account or whichever way you desire to receive
>> your payment.Take note of that and i will advise you to contact him Asap
>> if you wish to receive your fund without any furtherwasting of time.
>> Thank You and Be Blessed.
>> Ms.Gertie Jenkins.
>
>
>
>

.

Hello Kevin
In response to your email massage, what is you to do now is make a choice of sending the $300.00 fee as outlined below
$300.00

~Money order

~PayPal

~Cash app

~AMX gift card
Awaits your timely response.
Friday, 09 September 2022, 09:46PM +01:00 from Kevin Day [email protected]:

Hi,

Sounds great, how can we proceed? We're interested in getting started pretty much immediately, as we could use this.

Kevin Day

CEO, MNesty, LLC

On 09/09/2022 13:39 PM, wrote:

> Attn: Kelly Day

>

> Greetings to you and your family, I've received and read your mail and

> as a human rights protester in connection with a member of the

> Compensation Award Committee, currently in Oklahoma It is a great

> pleasure to know that Ms.Gertie Jenkins and other victims around the

> globe has made mentioned of my good performance regarding the

> outstanding payment here and I must make it clear to you that with

> your maximum compliance in this, you will as well receive your total

> inheritance fund within three Bank working days without any hitches or

> hindrance as Ms.Gertie Jenkins and others.

>

> I have done this successfully for over two years now and the

> attestation of people like Ms.Gertie Jenkins is a pointer to the good

> work I have done to the satisfaction of our numerous clients who have

> been relieved of the nefarious and corrupt activities of several

> government officials who are hell bent on frustrating the efforts of

> genuine beneficiaries/claimants.

>

> So after going through your payment files, I've come to understand the

> inconveniences and financial commitments you have invested so far for

> the pursuit of this fund which was all to no avail.However,considering

> your efforts towards achieving this aim,we have come to maintain

> equity,justice and fairness in our dealings with beneficiaries such as

> yours, hence we have insisted that your funds should be reversed from

> the government treasury account and be released to you accordingly.

>

> However,due to humanitarian ground and sympathy and because I do not

> want your payment cancelled so I immediately called up the

> International Monetary Fund (IMF)Director" Mrs.Kristalina Georgieva to

> explain your matter to her as in regards to your payment and She

> personally called up a meeting which was resolved that all payments

> charges and any payment fees must be reduced to it's barest menial in

> order to enable you afford to pay the fee so that your payment will be

> released to you within three Bank working days. To this end it will

> interest you to know that every and any fee/charges required of you

> have been reduced to only the sum of $300.00 USD,this step is in order

> to enable you have this only fee paid so that your Release Approval

> Certificate and Legal Affidavit for support are procured and acquired

> in other to enable the speedy accelerated transfer/delivery of your

> $7,500,000.00 USD into any bank account of your choice.

>

> Please I want you to know that you have within 72hours to effect the

> required payment so we can clear/release and effect the

> transfer/delivery of your fund worth $7,500,000.00 USD in our care to

> any bank account of your choice, so I urge you to send the $300.00 USD

> through USPS OverNight Priority Mail, MONEY GRAM, WALMART to WALMART,

> with the information that will be supply to you in my next email

> message after I have heard back from you.

>

> I want you to know that I am indeed very sorry for any inconveniences

> or any delay this must have caused you in having your fund paid out to

> you long before now. You will never ever regret paying the fee, this

> is a promise to you after all your pains in the past as I am here to

> give you my best service as my word is my bond always.Finally,I want

> to use this opportunity to assure and guarantee to give you the best

> of my performance and after the transaction you will have enough

> reason to smile and make a good recommendation of my honesty just like

> Ms.Gertie Jenkins and others. Note: You have only two methods to

> receive this overdue payment, 1 is by Bank to Bank wire transfer, 2 is

> by crediting the funds into an ATM CARD and have it mail to your home

> address. The address info to send the only fee of $300.00 USD will be

> provided to you as soon as I heard back from you. I await your timely

> response. Thanks and remain blessed.

>

> Warmest regards

> Mr. Edward David

> Text or Call: 202-539-8959,immediately after reading this mail Its

> very urgent and important,

> Please acknowledge receipt.

>

>

>

> ---------------------------------------------------------------------------=

> ------------------------

>

>

> Hello,

> can you give me an example of this? I would like to know roughly what

> it looks like.

>

> Kelly Day

> CEO, MNesty, LLC

>

> On 23/08/2022 21:43 PM, wrote:

> > UPDATE ABOUT YOUR COMPENSATION FUNDS

> > Note: if you found this email in your junk/spam, it's because of yourinte=

> rnet ISP server.

> > I am Ms. Gertie Jenkins, I am a US citizen, 58 years Old. I am one of tho=

> se people that took part in receiving Inheritance funds in East & West Afri=

> ca many years ago and they refused to pay me, I had paid different fees whi=

> le in the United States trying to get my funds from those banks and lottery=

> organizers but all to no avail.

> > So I decided to travel to Wright City, Oklahoma with all my compensation =

> documents, And I was directed by the Federal Bureau ofInvestigation Directo=

> r to contact Mr. Edward J.DAVID, who is a representative of the INTERNATION=

> AL MONETARY FUND (IMF),a Human Rights Activist and a member of the Compensa=

> tion Award Committee, currently in Wright City, Oklahoma and I contacted hi=

> m and he explained everything to me. He said whoever is contacting us throu=

> gh emails are fake, Mr. Edward J.DAVID personally directed me on how to cla=

> im my Inheritance fund.

> > He directed me to the paying bank for the claim of my Compensation paymen=

> t. Right now I am the happiest woman on earth because I have received my co=

> mpensation funds amounting to $7,500,000.00. Moreover, Mr.Edward J.DAVID sh=

> owed me the full information of those that are yet to receive their payment=

> s and those whose inheritance had not been paid and the list of all outstan=

> ding contractor that were owed that are yet to receive their payments and I=

> saw your email as one of the beneficiaries on the list he showed me, that =

> is why I decided to email you to stop dealing with those people, they are n=

> ot with your funds, they are only making money out of you. I will advise yo=

> u to contact Mr.Edward J.DAVID. Kindly send your personal details to him to=

> prove your identification such as below:

> > Full names:....Home address:....Current Phone No:....Country:............=

> ..

> > You have to contact him directly on this information below.

> > Compensation Award Office.Name : Mr.Edward J.DAVIDEmail: edwarddavid0460@=

> gmail.com

> > You really have to stop dealing with those people that are contacting you=

> and telling you that your fund is with them, it is not in anyway with them=

> , they are only taking advantage of you and they will dry you up until you =

> have nothing left.The only money I paid after I met Mr.Edward J.DAVID was f=

> or full legal affidavit to support my claim and approval of my compensation=

> funds release which will enable the transfer of the funds immediately to y=

> our bank account or whichever way you desire to receive your payment.Take n=

> ote of that and i will advise you to contact him Asap if you wish to receiv=

> e your fund without any furtherwasting of time.

> > Thank You and Be Blessed.

> > Ms.Gertie Jenkins.

>

> .

Hello good morning
This is to bring to your notice of understand that your fund is still available here in my possession, you're advice to get back to me asap for immediate transaction to commence without any further delay.
Friday, 09 September 2022, 09:46PM +01:00 from Kevin Day [email protected]:

Hi,

Sounds great, how can we proceed? We're interested in getting started pretty much immediately, as we could use this.

Kevin Day

CEO, MNesty, LLC

On 09/09/2022 13:39 PM, wrote:

> Attn: Kelly Day

>

> Greetings to you and your family, I've received and read your mail and

> as a human rights protester in connection with a member of the

> Compensation Award Committee, currently in Oklahoma It is a great

> pleasure to know that Ms.Gertie Jenkins and other victims around the

> globe has made mentioned of my good performance regarding the

> outstanding payment here and I must make it clear to you that with

> your maximum compliance in this, you will as well receive your total

> inheritance fund within three Bank working days without any hitches or

> hindrance as Ms.Gertie Jenkins and others.

>

> I have done this successfully for over two years now and the

> attestation of people like Ms.Gertie Jenkins is a pointer to the good

> work I have done to the satisfaction of our numerous clients who have

> been relieved of the nefarious and corrupt activities of several

> government officials who are hell bent on frustrating the efforts of

> genuine beneficiaries/claimants.

>

> So after going through your payment files, I've come to understand the

> inconveniences and financial commitments you have invested so far for

> the pursuit of this fund which was all to no avail.However,considering

> your efforts towards achieving this aim,we have come to maintain

> equity,justice and fairness in our dealings with beneficiaries such as

> yours, hence we have insisted that your funds should be reversed from

> the government treasury account and be released to you accordingly.

>

> However,due to humanitarian ground and sympathy and because I do not

> want your payment cancelled so I immediately called up the

> International Monetary Fund (IMF)Director" Mrs.Kristalina Georgieva to

> explain your matter to her as in regards to your payment and She

> personally called up a meeting which was resolved that all payments

> charges and any payment fees must be reduced to it's barest menial in

> order to enable you afford to pay the fee so that your payment will be

> released to you within three Bank working days. To this end it will

> interest you to know that every and any fee/charges required of you

> have been reduced to only the sum of $300.00 USD,this step is in order

> to enable you have this only fee paid so that your Release Approval

> Certificate and Legal Affidavit for support are procured and acquired

> in other to enable the speedy accelerated transfer/delivery of your

> $7,500,000.00 USD into any bank account of your choice.

>

> Please I want you to know that you have within 72hours to effect the

> required payment so we can clear/release and effect the

> transfer/delivery of your fund worth $7,500,000.00 USD in our care to

> any bank account of your choice, so I urge you to send the $300.00 USD

> through USPS OverNight Priority Mail, MONEY GRAM, WALMART to WALMART,

> with the information that will be supply to you in my next email

> message after I have heard back from you.

>

> I want you to know that I am indeed very sorry for any inconveniences

> or any delay this must have caused you in having your fund paid out to

> you long before now. You will never ever regret paying the fee, this

> is a promise to you after all your pains in the past as I am here to

> give you my best service as my word is my bond always.Finally,I want

> to use this opportunity to assure and guarantee to give you the best

> of my performance and after the transaction you will have enough

> reason to smile and make a good recommendation of my honesty just like

> Ms.Gertie Jenkins and others. Note: You have only two methods to

> receive this overdue payment, 1 is by Bank to Bank wire transfer, 2 is

> by crediting the funds into an ATM CARD and have it mail to your home

> address. The address info to send the only fee of $300.00 USD will be

> provided to you as soon as I heard back from you. I await your timely

> response. Thanks and remain blessed.

>

> Warmest regards

> Mr. Edward David

> Text or Call: 202-539-8959,immediately after reading this mail Its

> very urgent and important,

> Please acknowledge receipt.

>

>

>

> ---------------------------------------------------------------------------=

> ------------------------

>

>

> Hello,

> can you give me an example of this? I would like to know roughly what

> it looks like.

>

> Kelly Day

> CEO, MNesty, LLC

>

> On 23/08/2022 21:43 PM, wrote:

> > UPDATE ABOUT YOUR COMPENSATION FUNDS

> > Note: if you found this email in your junk/spam, it's because of yourinte=

> rnet ISP server.

> > I am Ms. Gertie Jenkins, I am a US citizen, 58 years Old. I am one of tho=

> se people that took part in receiving Inheritance funds in East & West Afri=

> ca many years ago and they refused to pay me, I had paid different fees whi=

> le in the United States trying to get my funds from those banks and lottery=

> organizers but all to no avail.

> > So I decided to travel to Wright City, Oklahoma with all my compensation =

> documents, And I was directed by the Federal Bureau ofInvestigation Directo=

> r to contact Mr. Edward J.DAVID, who is a representative of the INTERNATION=

> AL MONETARY FUND (IMF),a Human Rights Activist and a member of the Compensa=

> tion Award Committee, currently in Wright City, Oklahoma and I contacted hi=

> m and he explained everything to me. He said whoever is contacting us throu=

> gh emails are fake, Mr. Edward J.DAVID personally directed me on how to cla=

> im my Inheritance fund.

> > He directed me to the paying bank for the claim of my Compensation paymen=

> t. Right now I am the happiest woman on earth because I have received my co=

> mpensation funds amounting to $7,500,000.00. Moreover, Mr.Edward J.DAVID sh=

> owed me the full information of those that are yet to receive their payment=

> s and those whose inheritance had not been paid and the list of all outstan=

> ding contractor that were owed that are yet to receive their payments and I=

> saw your email as one of the beneficiaries on the list he showed me, that =

> is why I decided to email you to stop dealing with those people, they are n=

> ot with your funds, they are only making money out of you. I will advise yo=

> u to contact Mr.Edward J.DAVID. Kindly send your personal details to him to=

> prove your identification such as below:

> > Full names:....Home address:....Current Phone No:....Country:............=

> ..

> > You have to contact him directly on this information below.

> > Compensation Award Office.Name : Mr.Edward J.DAVIDEmail: edwarddavid0460@=

> gmail.com

> > You really have to stop dealing with those people that are contacting you=

> and telling you that your fund is with them, it is not in anyway with them=

> , they are only taking advantage of you and they will dry you up until you =

> have nothing left.The only money I paid after I met Mr.Edward J.DAVID was f=

> or full legal affidavit to support my claim and approval of my compensation=

> funds release which will enable the transfer of the funds immediately to y=

> our bank account or whichever way you desire to receive your payment.Take n=

> ote of that and i will advise you to contact him Asap if you wish to receiv=

> e your fund without any furtherwasting of time.

> > Thank You and Be Blessed.

> > Ms.Gertie Jenkins.

>

> .

Federal Reserve Bank of New York
33 Liberty St, New York, NY 10045, USA
Tel: +1 (201) 720-9881,

Attention: Beneficiary, Kyle 

Notice:
this is to acknowledge receipt of your email with content noted
regarding the release of your approved fund worth US$10.5 Million United
States Dollars Only from the United Nations and World Bank.

However:
be informed that the Federal Reserve Bank has been mandated by the
United Nations and World Bank Organization to offset your due Payment
Valued US$10.5 Million with immediate effect.

Meanwhile, kindly reconfirm the information below to enable us to proceed further and start the processing of your fund.

Carefully file the information below:

Full Name:
Residential Address:
Mobile Number:
Date of Birth:
Nationality:
A copy of your Driver License:

We look forward to hearing back from you immediately when you receive this message. Attached in this message is my ID Card.

Thank
you for choosing the Federal Reserve Bank of New York. We appreciate
the Opportunity to serve you. Do not hesitate to ask question (s) where
you consider necessary for clarification.

                    Congratulations,

Thanks and God Bless You

Yours Sincerely
Mr. Jerome Powell
Chairman Director Federal Reserve Bank of New York

  Greetings to you! Would you be interested in purchasing the B2B email lists based on title, geography or industry Database? Please pick a number that describes your response,        1. Yes - I’m interested & Send counts and cost of the database        2. No - Opt-Out (NOT interested)
Let me know your interest so that I can send you additional Information in my next email.Target Industry __________? Job Title __________? Geography_____________?  Regards,Barbara WilsonBusiness Executive If you don't wish to receive emails from us reply back with "Opt-Out ". 

HiWriting to check if you have received my previous email. Let me know if you are interested in the list through which you can get potential clients for your sales team. Awaiting your response. Best Regards,Barbara Wilson From: [email protected] <[email protected]>
Sent: 16 December 2022 03:12
To: [email protected]
Subject: B2B email lists    Greetings to you! Would you be interested in purchasing the B2B email lists based on title, geography or industry Database? Please pick a number that describes your response,        1. Yes - I’m interested & Send counts and cost of the database        2. No - Opt-Out (NOT interested)
Let me know your interest so that I can send you additional Information in my next email.Target Industry __________? Job Title __________? Geography_____________?  Regards,Barbara WilsonBusiness Executive If you don't wish to receive emails from us reply back with "Opt-Out ". 

Dear Sir,
Thank you for your email Please let us know which compound you require Accordingly we will share information for it 
On Fri, Dec 30, 2022 at 10:03 AM Kishor Chokhani <[email protected]> wrote:

---------- Forwarded message ---------
From: Kimberly Day <[email protected]>
Date: Wed, 21 Dec 2022 at 23:51
Subject: Re: Anti-Cancer Compounds For Research
To: <[email protected]>

Hello,

can you give me an example of this? I would like to know roughly what it looks like.

Kimberly Day

CEO, MNesty, LLC

On 21/12/2022 06:22 AM,  wrote:

> Researcher,

>  

> We feel honored to introduce ourselves as one of the trading and

> sourcing companies based in India / China offering a wide range of research

> chemicals and biochemicals including novel life-science reagents, reference

> compounds and Natural compounds for laboratory and scientific use. The volume

> of our products ranges from milligrams to kilograms scale. We Offer  our

>  products to Research institutions , CRO’s , Biotech Companies  and

>  Universities all  over  the  world .

>

>  

>

> We currently are offering  below  compounds for  clinical trials

>  in  pack size of 5mg / 10mg / 20mg/ 50mg / 100mg / 200mg and

>  1000mg , bigger the  quantity the better  the  price .

>

>

>  

> Abaloparatide

>

> Abemaciclib

>

> Abiraterone

>

> Acalabrutinib

>

> Aclarubicin

>

> Afatinib

>

> Aflibercept

>

> Aldesleukin

>

> Alectinib

>

> Alemtuzumab

>

> Alitretinoin

>

> Alpelisib

>

> Altretamine

>

> Ambrisentan

>

> Amivantamab

>

> Amorolfine Hcl

>

> Amrubicin

>

> Amsacrine

>

> Anagrelide

>

> Anastrozole

>

> Apalutamide

>

> Apixaban

>

> Apremilast

>

> Argatroban Monohydrate

>

> Asciminib

>

> Atezolizumab

>

> Atosiban

>

> Avapritinib

>

> Avelumab

>

> Axitinib

>

> Azacitidine

>

> Belantamab Mafodotin

>

> Belinostat

>

> Belotecan

>

> Bendamustine

>

> Benzphetamine Hcl

>

> Betiatide

>

> Bevacizumab

>

> Bexarotene

>

> Bicalutamide

>

> Binimetinib

>

> Bivalirudin

>

> Bleomycin

>

> Blinatumomab

>

> Bortezomib

>

> Bosutinib

>

> Bremelanotide

>

> Brigatinib

>

> Brivaracetam

>

> Buprenorphine

>

> Buserelin

>

> Busulfan

>

> Butabarbital Base/Sodium

>

> Butalbital

>

> Cabazitaxel

>

> Cabozantinib

>

> Canagliflozin

>

> Candesartan Cilexetil

>

> Capecitabine

>

> Capmatinib

>

> Carboplatin

>

> Carfilzomib

>

> Cariprazine Hcl

>

> Carmofur

>

> Carmustine

>

> Cemiplimab

>

> Ceritinib

>

> Cetuximab

>

> Cilastatin Sodium

>

> Cilazapril

>

> Cisplatin

>

> Cladribine

>

> Cobimetinib

>

> Colesevelam

>

> Copanlisib

>

> Crizotinib

>

> Cytarabine

>

> Dabrafenib

>

> Dacarbazine

>

> Dacomitinib

>

> Dactinomycin

>

> Dalfampridine

>

> Dapagliflozin

>

> Daratumumab

>

> Darolutamide

>

> Dasatinib

>

> Daunorubicin

>

> Decitabine

>

> Deferasirox

>

> Deferiprone

>

> Degarelix

>

> Denosumab

>

> Dexmedetomidine

>

> Dexrazoxane

>

> Diflunisal

>

> Dihydrocodeine Bitartrate

>

> Docetaxel

>

> Dofetilide

>

> Dolasetron Mesylate

>

> Dolutegravir

>

> Doripenem

>

> Dostarlimab

>

> Doxercalciferol

>

> Doxorubicin

>

> Droxidopa

>

> Durvalumab

>

> Duvelisib

>

> Edaravone

>

> Edotreotide

>

> Elagolix Sodium

>

> Elotuzumab

>

> Eluxadoline

>

> Emapalumab

>

> Empagliflozin

>

> Enasidenib

>

> Encorafenib

>

> Entrectinib

>

> Enzalutamide

>

> Epirubicin

>

> Erdafitinib

>

> Eribulin

>

> Erlotinib

>

> Ertapenem Sodium

>

> Estramustine

>

> Etelcalcetide Hcl

>

> Everolimus

>

> Exemestane

>

> Febuxostat

>

> Fedratinib

>

> Felbamate

>

> Fingolimod Hcl

>

> Flecainide Acetate

>

> Fludarabine

>

> Fluorouracil

>

> Fluoxymesterone

>

> Fluticasone Propionate

>

> Fluvastatin Sodium

>

> Fluvoxamine Maleate

>

> Foscarnet Sodium

>

> Fosphenytoin Sodium

>

> Fotemustine

>

> Fulvestrant

>

> Gefitinib

>

> Gemcitabine

>

> Gilteritinib

>

> Glasdegib

>

> Goserelin

>

> Ibandronate Sodium

>

> Ibritumomab Tiuxetan

>

> Ibrutinib

>

> Ibutilide Fumarate

>

> Icatibant Acetate

>

> Idarubicin

>

> Idelalisib

>

> Imatinib

>

> Iobenguane

>

> Ipilimumab

>

> Irbesartan

>

> Irinotecan

>

> Isatuximab

>

> Isotretinoin

>

> Ivosidenib

>

> Ixabepilone

>

> Ixazomib

>

> Lanreotide

>

> Lapatinib

>

> Larotrectinib

>

> Lercanidipine Hcl

>

> Ledipasvir

>

> Leflunomide

>

> Lenalidomide

>

> Lenvatinib

>

> Leucovorin Calcium, USP

>

> Leuprolide

>

> Levorphanol

>

> Levosimendan

>

> Levothyroxine Sodium

>

> Linaclotide

>

> Linagliptin

>

> Lomustine

>

> Loncastuximab Tesirine

>

> Lorlatinib

>

> Loteprednol Etabonate

>

> Lubiprostone

>

> Luliconazole

>

> Lumacaftor

>

> Lurasidone Hcl

>

> Lurbinectedin

>

> Margetuximab

>

> Mefloquine

>

> Melphalan

>

> Memantine

>

> Mesalamine

>

> Methamphetamine Hcl

>

> Methenamine

>

> Methotrexate

>

> Methylphenidate Base

>

> Metoclopramide HCl

>

> Midodrine

>

> Midostaurin

>

> Mifamurtide

>

> Milrinone

>

> Mitomycin

>

> Mitoxantrone

>

> Mobocertinib

>

> Mogamulizumab

>

> Mosunetuzumab

>

> Moxetumomab Pasudotox

>

> Mycophenolate Mofetil

>

> Naltrexone Hcl

>

> Naxitamab

>

> Necitumumab

>

> Nelarabine

>

> Neratinib

>

> Netarsudil

>

> Nilotinib

>

> Nilutamide

>

> Nintedanib

>

> Niraparib

>

> Nisoldipine

>

> Nivolumab

>

> Octreotide Acetate

>

> Olaparib

>

> Olaratumab

>

> Omacetaxine Mepesuccinate

>

> Oripavine

>

> Osimertinib

>

> Oxaliplatin

>

> Oxcarbazepine

>

> Oxetacaine

>

> Oxycodone Hcl

>

> Paclitaxel

>

> Padeliporfin

>

> Palbociclib

>

> Paliperidone

>

> Palonosetron HCl

>

> Pamabrom

>

> Panitumumab

>

> Panobinostat

>

> Pazopanib

> Pegaspargase

>

> Pembrolizumab

>

> Pemetrexed

>

> Pemigatinib

>

> Pentamidine

>

> Pentazocine

>

> Pentetreotide

>

> Pentoxifylline

>

> Pertuzumab

>

> Pimavanserin Tartrate

>

> Pipobroman

>

> Pirarubicin

>

> Pixantrone

>

> Plecanatide

>

> Pomalidomide

>

> Ponatinib

>

> Porfimer

>

> Pralatrexate

>

> Pralsetinib

>

> Racotumomab

>

> Raltitrexed

>

> Ramucirumab

>

> Ranimustine

>

> Regorafenib

>

> Ribociclib

>

> Rifaximin

>

> Ripretinib

>

> Ritonavir

>

> Rituximab

>

> Rivastigmine Tartrate

>

> Rizatriptan Benzoate

>

> Romidepsin

>

> Ropivacaine Hydrochloride

>

> Roxadustat

>

> Rucaparib

>

> Ruxolitinib

>

> Sacituzumab Govitecan

>

> Safinamide

>

> Samidorphan

>

> Saxagliptin

>

> Selinexor

>

> Selpercatinib

>

> Semaglutide

>

> Sincalide

>

> Siponimod Fumarate

>

> Sonidegib

>

> Sorafenib

>

> Sotorasib

>

> Sunitinib

>

> Tafamidis

>

> Tafasitamab

>

> Tagraxofusp

>

> Talazoparib

>

> Tamoxifen

>

> Tamsulosin Hcl

>

> Tazemetostat

>

> Tebentafusp

>

> Tegafur

>

> Temoporfin

>

> Temozolomide

>

> Temsirolimus

>

> Tepotinib

>

> Teriflunomide

>

> Terlipressin  Acetate

>

> Tetracosactide

>

> Tezacaftor

>

> Tigecycline

>

> Tivozanib

>

> Tolvaptan

>

> Trastuzumab

>

> Treprostinil

>

> Tretinoin

>

> Tucatinib

>

> Umbralisib

>

> Upadacitinib

>

> Valganciclovir Hcl

>

> Valrubicin

>

> Vandetanib

>

> Vemurafenib

>

> Vinblastine

>

> Vincristine

>

> Vindesine

>

> Vinflunine

>

> Vinorelbine

>

> Vorinostat

>

> Zanubrutinib

>

> Zileuton

>

> Zolmitriptan

> Note  :

>

> ·         Products are intended only for laboratory

> research and analytical use. They are not for human or veterinary use.

>

> ·          We  dont  deal  in  any

>  controlled substances  products .

>

> ·          Products protected by patent in the country

> are not offered for sale to that country. It is buyer’s responsibility to

> comply with the rules and regulations of his/her country.

>

>  

>

> Kindly  let us know  your  interest . Euroasia’s  welcome

>  all  inquiries  pertaining to research of any Therapeutic

> classifications .

>

>  

>

> Warm  Regards,

> Euroasia's

> Kishore Chokhani

>

Dear Sir
Below mentioned is my direct contact numberKindly share your requirements we will send you offer Sushmita ChakarvortyMarketing ExecutiveA   207 Parvati Industrial Estate, Sunmill Compound, Lower Parel, Mumbai 400013T   +91 22 67745506  M   +91 9594216860E   [email protected]  S   sushmita.chakravorty3USA   710 New Brunswick Avenue, Rahway, NJ 07065 www.euroasiachem.com | www.euroasiasrnd.comPlease consider the environment before printing this emailIMPORTANT: The contents of this email and any attachments are confidential. It is strictly forbidden to share any part of this message with any third party, without a written consent of the sender. If you received this message by mistake, please reply to this message and follow with its deletion, so that we can ensure such a mistake does not occur in the future.

On Fri, Dec 30, 2022 at 3:37 PM Kevin Day <[email protected]> wrote:
Hello,

I am a bit busy now, but I am definitely interested. When can we talk?

Kevin Day

CEO, MNesty, LLC

On 30/12/2022 05:06 AM,  wrote:

> Dear Sir,

> Thank you for your email Please let us know which compound you require Accordingly we will share information for it 

> On Fri, Dec 30, 2022 at 10:03 AM Kishor Chokhani <[email protected]> wrote:

>

>

> ---------- Forwarded message ---------

> From: Kimberly Day <[email protected]>

> Date: Wed, 21 Dec 2022 at 23:51

> Subject: Re: Anti-Cancer Compounds For Research

> To:  <[email protected]>

>

>

> Hello,

>

> can you give me an example of this? I would like to know roughly what it looks like.

>

>

>

> Kimberly Day

>

> CEO, MNesty, LLC

>

>

>

> On 21/12/2022 06:22 AM,  wrote:

>

> > Researcher,

>

> >  

>

> > We feel honored to introduce ourselves as one of the trading and

>

> > sourcing companies based in India / China offering a wide range of research

>

> > chemicals and biochemicals including novel life-science reagents, reference

>

> > compounds and Natural compounds for laboratory and scientific use. The volume

>

> > of our products ranges from milligrams to kilograms scale. We Offer  our

>

> >  products to Research institutions , CRO’s , Biotech Companies  and

>

> >  Universities all  over  the  world .

>

> >

>

> >  

>

> >

>

> > We currently are offering  below  compounds for  clinical trials

>

> >  in  pack size of 5mg / 10mg / 20mg/ 50mg / 100mg / 200mg and

>

> >  1000mg , bigger the  quantity the better  the  price .

>

> >

>

> >

>

> >  

>

> > Abaloparatide

>

> >

>

> > Abemaciclib

>

> >

>

> > Abiraterone

>

> >

>

> > Acalabrutinib

>

> >

>

> > Aclarubicin

>

> >

>

> > Afatinib

>

> >

>

> > Aflibercept

>

> >

>

> > Aldesleukin

>

> >

>

> > Alectinib

>

> >

>

> > Alemtuzumab

>

> >

>

> > Alitretinoin

>

> >

>

> > Alpelisib

>

> >

>

> > Altretamine

>

> >

>

> > Ambrisentan

>

> >

>

> > Amivantamab

>

> >

>

> > Amorolfine Hcl

>

> >

>

> > Amrubicin

>

> >

>

> > Amsacrine

>

> >

>

> > Anagrelide

>

> >

>

> > Anastrozole

>

> >

>

> > Apalutamide

>

> >

>

> > Apixaban

>

> >

>

> > Apremilast

>

> >

>

> > Argatroban Monohydrate

>

> >

>

> > Asciminib

>

> >

>

> > Atezolizumab

>

> >

>

> > Atosiban

>

> >

>

> > Avapritinib

>

> >

>

> > Avelumab

>

> >

>

> > Axitinib

>

> >

>

> > Azacitidine

>

> >

>

> > Belantamab Mafodotin

>

> >

>

> > Belinostat

>

> >

>

> > Belotecan

>

> >

>

> > Bendamustine

>

> >

>

> > Benzphetamine Hcl

>

> >

>

> > Betiatide

>

> >

>

> > Bevacizumab

>

> >

>

> > Bexarotene

>

> >

>

> > Bicalutamide

>

> >

>

> > Binimetinib

>

> >

>

> > Bivalirudin

>

> >

>

> > Bleomycin

>

> >

>

> > Blinatumomab

>

> >

>

> > Bortezomib

>

> >

>

> > Bosutinib

>

> >

>

> > Bremelanotide

>

> >

>

> > Brigatinib

>

> >

>

> > Brivaracetam

>

> >

>

> > Buprenorphine

>

> >

>

> > Buserelin

>

> >

>

> > Busulfan

>

> >

>

> > Butabarbital Base/Sodium

>

> >

>

> > Butalbital

>

> >

>

> > Cabazitaxel

>

> >

>

> > Cabozantinib

>

> >

>

> > Canagliflozin

>

> >

>

> > Candesartan Cilexetil

>

> >

>

> > Capecitabine

>

> >

>

> > Capmatinib

>

> >

>

> > Carboplatin

>

> >

>

> > Carfilzomib

>

> >

>

> > Cariprazine Hcl

>

> >

>

> > Carmofur

>

> >

>

> > Carmustine

>

> >

>

> > Cemiplimab

>

> >

>

> > Ceritinib

>

> >

>

> > Cetuximab

>

> >

>

> > Cilastatin Sodium

>

> >

>

> > Cilazapril

>

> >

>

> > Cisplatin

>

> >

>

> > Cladribine

>

> >

>

> > Cobimetinib

>

> >

>

> > Colesevelam

>

> >

>

> > Copanlisib

>

> >

>

> > Crizotinib

>

> >

>

> > Cytarabine

>

> >

>

> > Dabrafenib

>

> >

>

> > Dacarbazine

>

> >

>

> > Dacomitinib

>

> >

>

> > Dactinomycin

>

> >

>

> > Dalfampridine

>

> >

>

> > Dapagliflozin

>

> >

>

> > Daratumumab

>

> >

>

> > Darolutamide

>

> >

>

> > Dasatinib

>

> >

>

> > Daunorubicin

>

> >

>

> > Decitabine

>

> >

>

> > Deferasirox

>

> >

>

> > Deferiprone

>

> >

>

> > Degarelix

>

> >

>

> > Denosumab

>

> >

>

> > Dexmedetomidine

>

> >

>

> > Dexrazoxane

>

> >

>

> > Diflunisal

>

> >

>

> > Dihydrocodeine Bitartrate

>

> >

>

> > Docetaxel

>

> >

>

> > Dofetilide

>

> >

>

> > Dolasetron Mesylate

>

> >

>

> > Dolutegravir

>

> >

>

> > Doripenem

>

> >

>

> > Dostarlimab

>

> >

>

> > Doxercalciferol

>

> >

>

> > Doxorubicin

>

> >

>

> > Droxidopa

>

> >

>

> > Durvalumab

>

> >

>

> > Duvelisib

>

> >

>

> > Edaravone

>

> >

>

> > Edotreotide

>

> >

>

> > Elagolix Sodium

>

> >

>

> > Elotuzumab

>

> >

>

> > Eluxadoline

>

> >

>

> > Emapalumab

>

> >

>

> > Empagliflozin

>

> >

>

> > Enasidenib

>

> >

>

> > Encorafenib

>

> >

>

> > Entrectinib

>

> >

>

> > Enzalutamide

>

> >

>

> > Epirubicin

>

> >

>

> > Erdafitinib

>

> >

>

> > Eribulin

>

> >

>

> > Erlotinib

>

> >

>

> > Ertapenem Sodium

>

> >

>

> > Estramustine

>

> >

>

> > Etelcalcetide Hcl

>

> >

>

> > Everolimus

>

> >

>

> > Exemestane

>

> >

>

> > Febuxostat

>

> >

>

> > Fedratinib

>

> >

>

> > Felbamate

>

> >

>

> > Fingolimod Hcl

>

> >

>

> > Flecainide Acetate

>

> >

>

> > Fludarabine

>

> >

>

> > Fluorouracil

>

> >

>

> > Fluoxymesterone

>

> >

>

> > Fluticasone Propionate

>

> >

>

> > Fluvastatin Sodium

>

> >

>

> > Fluvoxamine Maleate

>

> >

>

> > Foscarnet Sodium

>

> >

>

> > Fosphenytoin Sodium

>

> >

>

> > Fotemustine

>

> >

>

> > Fulvestrant

>

> >

>

> > Gefitinib

>

> >

>

> > Gemcitabine

>

> >

>

> > Gilteritinib

>

> >

>

> > Glasdegib

>

> >

>

> > Goserelin

>

> >

>

> > Ibandronate Sodium

>

> >

>

> > Ibritumomab Tiuxetan

>

> >

>

> > Ibrutinib

>

> >

>

> > Ibutilide Fumarate

>

> >

>

> > Icatibant Acetate

>

> >

>

> > Idarubicin

>

> >

>

> > Idelalisib

>

> >

>

> > Imatinib

>

> >

>

> > Iobenguane

>

> >

>

> > Ipilimumab

>

> >

>

> > Irbesartan

>

> >

>

> > Irinotecan

>

> >

>

> > Isatuximab

>

> >

>

> > Isotretinoin

>

> >

>

> > Ivosidenib

>

> >

>

> > Ixabepilone

>

> >

>

> > Ixazomib

>

> >

>

> > Lanreotide

>

> >

>

> > Lapatinib

>

> >

>

> > Larotrectinib

>

> >

>

> > Lercanidipine Hcl

>

> >

>

> > Ledipasvir

>

> >

>

> > Leflunomide

>

> >

>

> > Lenalidomide

>

> >

>

> > Lenvatinib

>

> >

>

> > Leucovorin Calcium, USP

>

> >

>

> > Leuprolide

>

> >

>

> > Levorphanol

>

> >

>

> > Levosimendan

>

> >

>

> > Levothyroxine Sodium

>

> >

>

> > Linaclotide

>

> >

>

> > Linagliptin

>

> >

>

> > Lomustine

>

> >

>

> > Loncastuximab Tesirine

>

> >

>

> > Lorlatinib

>

> >

>

> > Loteprednol Etabonate

>

> >

>

> > Lubiprostone

>

> >

>

> > Luliconazole

>

> >

>

> > Lumacaftor

>

> >

>

> > Lurasidone Hcl

>

> >

>

> > Lurbinectedin

>

> >

>

> > Margetuximab

>

> >

>

> > Mefloquine

>

> >

>

> > Melphalan

>

> >

>

> > Memantine

>

> >

>

> > Mesalamine

>

> >

>

> > Methamphetamine Hcl

>

> >

>

> > Methenamine

>

> >

>

> > Methotrexate

>

> >

>

> > Methylphenidate Base

>

> >

>

> > Metoclopramide HCl

>

> >

>

> > Midodrine

>

> >

>

> > Midostaurin

>

> >

>

> > Mifamurtide

>

> >

>

> > Milrinone

>

> >

>

> > Mitomycin

>

> >

>

> > Mitoxantrone

>

> >

>

> > Mobocertinib

>

> >

>

> > Mogamulizumab

>

> >

>

> > Mosunetuzumab

>

> >

>

> > Moxetumomab Pasudotox

>

> >

>

> > Mycophenolate Mofetil

>

> >

>

> > Naltrexone Hcl

>

> >

>

> > Naxitamab

>

> >

>

> > Necitumumab

>

> >

>

> > Nelarabine

>

> >

>

> > Neratinib

>

> >

>

> > Netarsudil

>

> >

>

> > Nilotinib

>

> >

>

> > Nilutamide

>

> >

>

> > Nintedanib

>

> >

>

> > Niraparib

>

> >

>

> > Nisoldipine

>

> >

>

> > Nivolumab

>

> >

>

> > Octreotide Acetate

>

> >

>

> > Olaparib

>

> >

>

> > Olaratumab

>

> >

>

> > Omacetaxine Mepesuccinate

>

> >

>

> > Oripavine

>

> >

>

> > Osimertinib

>

> >

>

> > Oxaliplatin

>

> >

>

> > Oxcarbazepine

>

> >

>

> > Oxetacaine

>

> >

>

> > Oxycodone Hcl

>

> >

>

> > Paclitaxel

>

> >

>

> > Padeliporfin

>

> >

>

> > Palbociclib

>

> >

>

> > Paliperidone

>

> >

>

> > Palonosetron HCl

>

> >

>

> > Pamabrom

>

> >

>

> > Panitumumab

>

> >

>

> > Panobinostat

>

> >

>

> > Pazopanib

>

> > Pegaspargase

>

> >

>

> > Pembrolizumab

>

> >

>

> > Pemetrexed

>

> >

>

> > Pemigatinib

>

> >

>

> > Pentamidine

>

> >

>

> > Pentazocine

>

> >

>

> > Pentetreotide

>

> >

>

> > Pentoxifylline

>

> >

>

> > Pertuzumab

>

> >

>

> > Pimavanserin Tartrate

>

> >

>

> > Pipobroman

>

> >

>

> > Pirarubicin

>

> >

>

> > Pixantrone

>

> >

>

> > Plecanatide

>

> >

>

> > Pomalidomide

>

> >

>

> > Ponatinib

>

> >

>

> > Porfimer

>

> >

>

> > Pralatrexate

>

> >

>

> > Pralsetinib

>

> >

>

> > Racotumomab

>

> >

>

> > Raltitrexed

>

> >

>

> > Ramucirumab

>

> >

>

> > Ranimustine

>

> >

>

> > Regorafenib

>

> >

>

> > Ribociclib

>

> >

>

> > Rifaximin

>

> >

>

> > Ripretinib

>

> >

>

> > Ritonavir

>

> >

>

> > Rituximab

>

> >

>

> > Rivastigmine Tartrate

>

> >

>

> > Rizatriptan Benzoate

>

> >

>

> > Romidepsin

>

> >

>

> > Ropivacaine Hydrochloride

>

> >

>

> > Roxadustat

>

> >

>

> > Rucaparib

>

> >

>

> > Ruxolitinib

>

> >

>

> > Sacituzumab Govitecan

>

> >

>

> > Safinamide

>

> >

>

> > Samidorphan

>

> >

>

> > Saxagliptin

>

> >

>

> > Selinexor

>

> >

>

> > Selpercatinib

>

> >

>

> > Semaglutide

>

> >

>

> > Sincalide

>

> >

>

> > Siponimod Fumarate

>

> >

>

> > Sonidegib

>

> >

>

> > Sorafenib

>

> >

>

> > Sotorasib

>

> >

>

> > Sunitinib

>

> >

>

> > Tafamidis

>

> >

>

> > Tafasitamab

>

> >

>

> > Tagraxofusp

>

> >

>

> > Talazoparib

>

> >

>

> > Tamoxifen

>

> >

>

> > Tamsulosin Hcl

>

> >

>

> > Tazemetostat

>

> >

>

> > Tebentafusp

>

> >

>

> > Tegafur

>

> >

>

> > Temoporfin

>

> >

>

> > Temozolomide

>

> >

>

> > Temsirolimus

>

> >

>

> > Tepotinib

>

> >

>

> > Teriflunomide

>

> >

>

> > Terlipressin  Acetate

>

> >

>

> > Tetracosactide

>

> >

>

> > Tezacaftor

>

> >

>

> > Tigecycline

>

> >

>

> > Tivozanib

>

> >

>

> > Tolvaptan

>

> >

>

> > Trastuzumab

>

> >

>

> > Treprostinil

>

> >

>

> > Tretinoin

>

> >

>

> > Tucatinib

>

> >

>

> > Umbralisib

>

> >

>

> > Upadacitinib

>

> >

>

> > Valganciclovir Hcl

>

> >

>

> > Valrubicin

>

> >

>

> > Vandetanib

>

> >

>

> > Vemurafenib

>

> >

>

> > Vinblastine

>

> >

>

> > Vincristine

>

> >

>

> > Vindesine

>

> >

>

> > Vinflunine

>

> >

>

> > Vinorelbine

>

> >

>

> > Vorinostat

>

> >

>

> > Zanubrutinib

>

> >

>

> > Zileuton

>

> >

>

> > Zolmitriptan

>

> > Note  :

>

> >

>

> > ·         Products are intended only for laboratory

>

> > research and analytical use. They are not for human or veterinary use.

>

> >

>

> > ·          We  dont  deal  in  any

>

> >  controlled substances  products .

>

> >

>

> > ·          Products protected by patent in the country

>

> > are not offered for sale to that country. It is buyer’s responsibility to

>

> > comply with the rules and regulations of his/her country.

>

> >

>

> >  

>

> >

>

> > Kindly  let us know  your  interest . Euroasia’s  welcome

>

> >  all  inquiries  pertaining to research of any Therapeutic

>

> > classifications .

>

> >

>

> >  

>

> >

>

> > Warm  Regards,

>

> > Euroasia's

>

> > Kishore Chokhani

>

> >

>

>

>

>

>

>

>

>

>

Dear Sir,
We have mentioned in our introduction These are Anti-cancer compounds used for RND in universities Do you have any requirement for it?
On Sat, Dec 31, 2022 at 1:19 AM Kevin Day <[email protected]> wrote:
Hello,

That is reasonable, but do you think you can go into more detail about your main product? What is it about, exactly? Does it resemble https://photricity.com/flw/ajax/?

Kevin Day

CEO, MNesty, LLC

On 30/12/2022 10:08 AM,  wrote:

> Dear Sir

> Below mentioned is my direct contact numberKindly share your requirements we will send you offer Sushmita ChakarvortyMarketing ExecutiveA   207 Parvati Industrial Estate, Sunmill Compound, Lower Parel, Mumbai 400013T   +91 22 67745506  M   +91 9594216860E   [email protected]  S   sushmita.chakravorty3USA   710 New Brunswick Avenue, Rahway, NJ 07065 www.euroasiachem.com | www.euroasiasrnd.comPlease consider the environment before printing this emailIMPORTANT: The contents of this email and any attachments are confidential. It is strictly forbidden to share any part of this message with any third party, without a written consent of the sender. If you received this message by mistake, please reply to this message and follow with its deletion, so that we can ensure such a mistake does not occur in the future.

>

> On Fri, Dec 30, 2022 at 3:37 PM Kevin Day <[email protected]> wrote:

> Hello,

>

> I am a bit busy now, but I am definitely interested. When can we talk?

>

>

>

> Kevin Day

>

> CEO, MNesty, LLC

>

>

>

> On 30/12/2022 05:06 AM,  wrote:

>

> > Dear Sir,

>

> > Thank you for your email Please let us know which compound you require Accordingly we will share information for it 

>

> > On Fri, Dec 30, 2022 at 10:03 AM Kishor Chokhani <[email protected]> wrote:

>

> >

>

> >

>

> > ---------- Forwarded message ---------

>

> > From: Kimberly Day <[email protected]>

>

> > Date: Wed, 21 Dec 2022 at 23:51

>

> > Subject: Re: Anti-Cancer Compounds For Research

>

> > To:  <[email protected]>

>

> >

>

> >

>

> > Hello,

>

> >

>

> > can you give me an example of this? I would like to know roughly what it looks like.

>

> >

>

> >

>

> >

>

> > Kimberly Day

>

> >

>

> > CEO, MNesty, LLC

>

> >

>

> >

>

> >

>

> > On 21/12/2022 06:22 AM,  wrote:

>

> >

>

> > > Researcher,

>

> >

>

> > >  

>

> >

>

> > > We feel honored to introduce ourselves as one of the trading and

>

> >

>

> > > sourcing companies based in India / China offering a wide range of research

>

> >

>

> > > chemicals and biochemicals including novel life-science reagents, reference

>

> >

>

> > > compounds and Natural compounds for laboratory and scientific use. The volume

>

> >

>

> > > of our products ranges from milligrams to kilograms scale. We Offer  our

>

> >

>

> > >  products to Research institutions , CRO’s , Biotech Companies  and

>

> >

>

> > >  Universities all  over  the  world .

>

> >

>

> > >

>

> >

>

> > >  

>

> >

>

> > >

>

> >

>

> > > We currently are offering  below  compounds for  clinical trials

>

> >

>

> > >  in  pack size of 5mg / 10mg / 20mg/ 50mg / 100mg / 200mg and

>

> >

>

> > >  1000mg , bigger the  quantity the better  the  price .

>

> >

>

> > >

>

> >

>

> > >

>

> >

>

> > >  

>

> >

>

> > > Abaloparatide

>

> >

>

> > >

>

> >

>

> > > Abemaciclib

>

> >

>

> > >

>

> >

>

> > > Abiraterone

>

> >

>

> > >

>

> >

>

> > > Acalabrutinib

>

> >

>

> > >

>

> >

>

> > > Aclarubicin

>

> >

>

> > >

>

> >

>

> > > Afatinib

>

> >

>

> > >

>

> >

>

> > > Aflibercept

>

> >

>

> > >

>

> >

>

> > > Aldesleukin

>

> >

>

> > >

>

> >

>

> > > Alectinib

>

> >

>

> > >

>

> >

>

> > > Alemtuzumab

>

> >

>

> > >

>

> >

>

> > > Alitretinoin

>

> >

>

> > >

>

> >

>

> > > Alpelisib

>

> >

>

> > >

>

> >

>

> > > Altretamine

>

> >

>

> > >

>

> >

>

> > > Ambrisentan

>

> >

>

> > >

>

> >

>

> > > Amivantamab

>

> >

>

> > >

>

> >

>

> > > Amorolfine Hcl

>

> >

>

> > >

>

> >

>

> > > Amrubicin

>

> >

>

> > >

>

> >

>

> > > Amsacrine

>

> >

>

> > >

>

> >

>

> > > Anagrelide

>

> >

>

> > >

>

> >

>

> > > Anastrozole

>

> >

>

> > >

>

> >

>

> > > Apalutamide

>

> >

>

> > >

>

> >

>

> > > Apixaban

>

> >

>

> > >

>

> >

>

> > > Apremilast

>

> >

>

> > >

>

> >

>

> > > Argatroban Monohydrate

>

> >

>

> > >

>

> >

>

> > > Asciminib

>

> >

>

> > >

>

> >

>

> > > Atezolizumab

>

> >

>

> > >

>

> >

>

> > > Atosiban

>

> >

>

> > >

>

> >

>

> > > Avapritinib

>

> >

>

> > >

>

> >

>

> > > Avelumab

>

> >

>

> > >

>

> >

>

> > > Axitinib

>

> >

>

> > >

>

> >

>

> > > Azacitidine

>

> >

>

> > >

>

> >

>

> > > Belantamab Mafodotin

>

> >

>

> > >

>

> >

>

> > > Belinostat

>

> >

>

> > >

>

> >

>

> > > Belotecan

>

> >

>

> > >

>

> >

>

> > > Bendamustine

>

> >

>

> > >

>

> >

>

> > > Benzphetamine Hcl

>

> >

>

> > >

>

> >

>

> > > Betiatide

>

> >

>

> > >

>

> >

>

> > > Bevacizumab

>

> >

>

> > >

>

> >

>

> > > Bexarotene

>

> >

>

> > >

>

> >

>

> > > Bicalutamide

>

> >

>

> > >

>

> >

>

> > > Binimetinib

>

> >

>

> > >

>

> >

>

> > > Bivalirudin

>

> >

>

> > >

>

> >

>

> > > Bleomycin

>

> >

>

> > >

>

> >

>

> > > Blinatumomab

>

> >

>

> > >

>

> >

>

> > > Bortezomib

>

> >

>

> > >

>

> >

>

> > > Bosutinib

>

> >

>

> > >

>

> >

>

> > > Bremelanotide

>

> >

>

> > >

>

> >

>

> > > Brigatinib

>

> >

>

> > >

>

> >

>

> > > Brivaracetam

>

> >

>

> > >

>

> >

>

> > > Buprenorphine

>

> >

>

> > >

>

> >

>

> > > Buserelin

>

> >

>

> > >

>

> >

>

> > > Busulfan

>

> >

>

> > >

>

> >

>

> > > Butabarbital Base/Sodium

>

> >

>

> > >

>

> >

>

> > > Butalbital

>

> >

>

> > >

>

> >

>

> > > Cabazitaxel

>

> >

>

> > >

>

> >

>

> > > Cabozantinib

>

> >

>

> > >

>

> >

>

> > > Canagliflozin

>

> >

>

> > >

>

> >

>

> > > Candesartan Cilexetil

>

> >

>

> > >

>

> >

>

> > > Capecitabine

>

> >

>

> > >

>

> >

>

> > > Capmatinib

>

> >

>

> > >

>

> >

>

> > > Carboplatin

>

> >

>

> > >

>

> >

>

> > > Carfilzomib

>

> >

>

> > >

>

> >

>

> > > Cariprazine Hcl

>

> >

>

> > >

>

> >

>

> > > Carmofur

>

> >

>

> > >

>

> >

>

> > > Carmustine

>

> >

>

> > >

>

> >

>

> > > Cemiplimab

>

> >

>

> > >

>

> >

>

> > > Ceritinib

>

> >

>

> > >

>

> >

>

> > > Cetuximab

>

> >

>

> > >

>

> >

>

> > > Cilastatin Sodium

>

> >

>

> > >

>

> >

>

> > > Cilazapril

>

> >

>

> > >

>

> >

>

> > > Cisplatin

>

> >

>

> > >

>

> >

>

> > > Cladribine

>

> >

>

> > >

>

> >

>

> > > Cobimetinib

>

> >

>

> > >

>

> >

>

> > > Colesevelam

>

> >

>

> > >

>

> >

>

> > > Copanlisib

>

> >

>

> > >

>

> >

>

> > > Crizotinib

>

> >

>

> > >

>

> >

>

> > > Cytarabine

>

> >

>

> > >

>

> >

>

> > > Dabrafenib

>

> >

>

> > >

>

> >

>

> > > Dacarbazine

>

> >

>

> > >

>

> >

>

> > > Dacomitinib

>

> >

>

> > >

>

> >

>

> > > Dactinomycin

>

> >

>

> > >

>

> >

>

> > > Dalfampridine

>

> >

>

> > >

>

> >

>

> > > Dapagliflozin

>

> >

>

> > >

>

> >

>

> > > Daratumumab

>

> >

>

> > >

>

> >

>

> > > Darolutamide

>

> >

>

> > >

>

> >

>

> > > Dasatinib

>

> >

>

> > >

>

> >

>

> > > Daunorubicin

>

> >

>

> > >

>

> >

>

> > > Decitabine

>

> >

>

> > >

>

> >

>

> > > Deferasirox

>

> >

>

> > >

>

> >

>

> > > Deferiprone

>

> >

>

> > >

>

> >

>

> > > Degarelix

>

> >

>

> > >

>

> >

>

> > > Denosumab

>

> >

>

> > >

>

> >

>

> > > Dexmedetomidine

>

> >

>

> > >

>

> >

>

> > > Dexrazoxane

>

> >

>

> > >

>

> >

>

> > > Diflunisal

>

> >

>

> > >

>

> >

>

> > > Dihydrocodeine Bitartrate

>

> >

>

> > >

>

> >

>

> > > Docetaxel

>

> >

>

> > >

>

> >

>

> > > Dofetilide

>

> >

>

> > >

>

> >

>

> > > Dolasetron Mesylate

>

> >

>

> > >

>

> >

>

> > > Dolutegravir

>

> >

>

> > >

>

> >

>

> > > Doripenem

>

> >

>

> > >

>

> >

>

> > > Dostarlimab

>

> >

>

> > >

>

> >

>

> > > Doxercalciferol

>

> >

>

> > >

>

> >

>

> > > Doxorubicin

>

> >

>

> > >

>

> >

>

> > > Droxidopa

>

> >

>

> > >

>

> >

>

> > > Durvalumab

>

> >

>

> > >

>

> >

>

> > > Duvelisib

>

> >

>

> > >

>

> >

>

> > > Edaravone

>

> >

>

> > >

>

> >

>

> > > Edotreotide

>

> >

>

> > >

>

> >

>

> > > Elagolix Sodium

>

> >

>

> > >

>

> >

>

> > > Elotuzumab

>

> >

>

> > >

>

> >

>

> > > Eluxadoline

>

> >

>

> > >

>

> >

>

> > > Emapalumab

>

> >

>

> > >

>

> >

>

> > > Empagliflozin

>

> >

>

> > >

>

> >

>

> > > Enasidenib

>

> >

>

> > >

>

> >

>

> > > Encorafenib

>

> >

>

> > >

>

> >

>

> > > Entrectinib

>

> >

>

> > >

>

> >

>

> > > Enzalutamide

>

> >

>

> > >

>

> >

>

> > > Epirubicin

>

> >

>

> > >

>

> >

>

> > > Erdafitinib

>

> >

>

> > >

>

> >

>

> > > Eribulin

>

> >

>

> > >

>

> >

>

> > > Erlotinib

>

> >

>

> > >

>

> >

>

> > > Ertapenem Sodium

>

> >

>

> > >

>

> >

>

> > > Estramustine

>

> >

>

> > >

>

> >

>

> > > Etelcalcetide Hcl

>

> >

>

> > >

>

> >

>

> > > Everolimus

>

> >

>

> > >

>

> >

>

> > > Exemestane

>

> >

>

> > >

>

> >

>

> > > Febuxostat

>

> >

>

> > >

>

> >

>

> > > Fedratinib

>

> >

>

> > >

>

> >

>

> > > Felbamate

>

> >

>

> > >

>

> >

>

> > > Fingolimod Hcl

>

> >

>

> > >

>

> >

>

> > > Flecainide Acetate

>

> >

>

> > >

>

> >

>

> > > Fludarabine

>

> >

>

> > >

>

> >

>

> > > Fluorouracil

>

> >

>

> > >

>

> >

>

> > > Fluoxymesterone

>

> >

>

> > >

>

> >

>

> > > Fluticasone Propionate

>

> >

>

> > >

>

> >

>

> > > Fluvastatin Sodium

>

> >

>

> > >

>

> >

>

> > > Fluvoxamine Maleate

>

> >

>

> > >

>

> >

>

> > > Foscarnet Sodium

>

> >

>

> > >

>

> >

>

> > > Fosphenytoin Sodium

>

> >

>

> > >

>

> >

>

> > > Fotemustine

>

> >

>

> > >

>

> >

>

> > > Fulvestrant

>

> >

>

> > >

>

> >

>

> > > Gefitinib

>

> >

>

> > >

>

> >

>

> > > Gemcitabine

>

> >

>

> > >

>

> >

>

> > > Gilteritinib

>

> >

>

> > >

>

> >

>

> > > Glasdegib

>

> >

>

> > >

>

> >

>

> > > Goserelin

>

> >

>

> > >

>

> >

>

> > > Ibandronate Sodium

>

> >

>

> > >

>

> >

>

> > > Ibritumomab Tiuxetan

>

> >

>

> > >

>

> >

>

> > > Ibrutinib

>

> >

>

> > >

>

> >

>

> > > Ibutilide Fumarate

>

> >

>

> > >

>

> >

>

> > > Icatibant Acetate

>

> >

>

> > >

>

> >

>

> > > Idarubicin

>

> >

>

> > >

>

> >

>

> > > Idelalisib

>

> >

>

> > >

>

> >

>

> > > Imatinib

>

> >

>

> > >

>

> >

>

> > > Iobenguane

>

> >

>

> > >

>

> >

>

> > > Ipilimumab

>

> >

>

> > >

>

> >

>

> > > Irbesartan

>

> >

>

> > >

>

> >

>

> > > Irinotecan

>

> >

>

> > >

>

> >

>

> > > Isatuximab

>

> >

>

> > >

>

> >

>

> > > Isotretinoin

>

> >

>

> > >

>

> >

>

> > > Ivosidenib

>

> >

>

> > >

>

> >

>

> > > Ixabepilone

>

> >

>

> > >

>

> >

>

> > > Ixazomib

>

> >

>

> > >

>

> >

>

> > > Lanreotide

>

> >

>

> > >

>

> >

>

> > > Lapatinib

>

> >

>

> > >

>

> >

>

> > > Larotrectinib

>

> >

>

> > >

>

> >

>

> > > Lercanidipine Hcl

>

> >

>

> > >

>

> >

>

> > > Ledipasvir

>

> >

>

> > >

>

> >

>

> > > Leflunomide

>

> >

>

> > >

>

> >

>

> > > Lenalidomide

>

> >

>

> > >

>

> >

>

> > > Lenvatinib

>

> >

>

> > >

>

> >

>

> > > Leucovorin Calcium, USP

>

> >

>

> > >

>

> >

>

> > > Leuprolide

>

> >

>

> > >

>

> >

>

> > > Levorphanol

>

> >

>

> > >

>

> >

>

> > > Levosimendan

>

> >

>

> > >

>

> >

>

> > > Levothyroxine Sodium

>

> >

>

> > >

>

> >

>

> > > Linaclotide

>

> >

>

> > >

>

> >

>

> > > Linagliptin

>

> >

>

> > >

>

> >

>

> > > Lomustine

>

> >

>

> > >

>

> >

>

> > > Loncastuximab Tesirine

>

> >

>

> > >

>

> >

>

> > > Lorlatinib

>

> >

>

> > >

>

> >

>

> > > Loteprednol Etabonate

>

> >

>

> > >

>

> >

>

> > > Lubiprostone

>

> >

>

> > >

>

> >

>

> > > Luliconazole

>

> >

>

> > >

>

> >

>

> > > Lumacaftor

>

> >

>

> > >

>

> >

>

> > > Lurasidone Hcl

>

> >

>

> > >

>

> >

>

> > > Lurbinectedin

>

> >

>

> > >

>

> >

>

> > > Margetuximab

>

> >

>

> > >

>

> >

>

> > > Mefloquine

>

> >

>

> > >

>

> >

>

> > > Melphalan

>

> >

>

> > >

>

> >

>

> > > Memantine

>

> >

>

> > >

>

> >

>

> > > Mesalamine

>

> >

>

> > >

>

> >

>

> > > Methamphetamine Hcl

>

> >

>

> > >

>

> >

>

> > > Methenamine

>

> >

>

> > >

>

> >

>

> > > Methotrexate

>

> >

>

> > >

>

> >

>

> > > Methylphenidate Base

>

> >

>

> > >

>

> >

>

> > > Metoclopramide HCl

>

> >

>

> > >

>

> >

>

> > > Midodrine

>

> >

>

> > >

>

> >

>

> > > Midostaurin

>

> >

>

> > >

>

> >

>

> > > Mifamurtide

>

> >

>

> > >

>

> >

>

> > > Milrinone

>

> >

>

> > >

>

> >

>

> > > Mitomycin

>

> >

>

> > >

>

> >

>

> > > Mitoxantrone

>

> >

>

> > >

>

> >

>

> > > Mobocertinib

>

> >

>

> > >

>

> >

>

> > > Mogamulizumab

>

> >

>

> > >

>

> >

>

> > > Mosunetuzumab

>

> >

>

> > >

>

> >

>

> > > Moxetumomab Pasudotox

>

> >

>

> > >

>

> >

>

> > > Mycophenolate Mofetil

>

> >

>

> > >

>

> >

>

> > > Naltrexone Hcl

>

> >

>

> > >

>

> >

>

> > > Naxitamab

>

> >

>

> > >

>

> >

>

> > > Necitumumab

>

> >

>

> > >

>

> >

>

> > > Nelarabine

>

> >

>

> > >

>

> >

>

> > > Neratinib

>

> >

>

> > >

>

> >

>

> > > Netarsudil

>

> >

>

> > >

>

> >

>

> > > Nilotinib

>

> >

>

> > >

>

> >

>

> > > Nilutamide

>

> >

>

> > >

>

> >

>

> > > Nintedanib

>

> >

>

> > >

>

> >

>

> > > Niraparib

>

> >

>

> > >

>

> >

>

> > > Nisoldipine

>

> >

>

> > >

>

> >

>

> > > Nivolumab

>

> >

>

> > >

>

> >

>

> > > Octreotide Acetate

>

> >

>

> > >

>

> >

>

> > > Olaparib

>

> >

>

> > >

>

> >

>

> > > Olaratumab

>

> >

>

> > >

>

> >

>

> > > Omacetaxine Mepesuccinate

>

> >

>

> > >

>

> >

>

> > > Oripavine

>

> >

>

> > >

>

> >

>

> > > Osimertinib

>

> >

>

> > >

>

> >

>

> > > Oxaliplatin

>

> >

>

> > >

>

> >

>

> > > Oxcarbazepine

>

> >

>

> > >

>

> >

>

> > > Oxetacaine

>

> >

>

> > >

>

> >

>

> > > Oxycodone Hcl

>

> >

>

> > >

>

> >

>

> > > Paclitaxel

>

> >

>

> > >

>

> >

>

> > > Padeliporfin

>

> >

>

> > >

>

> >

>

> > > Palbociclib

>

> >

>

> > >

>

> >

>

> > > Paliperidone

>

> >

>

> > >

>

> >

>

> > > Palonosetron HCl

>

> >

>

> > >

>

> >

>

> > > Pamabrom

>

> >

>

> > >

>

> >

>

> > > Panitumumab

>

> >

>

> > >

>

> >

>

> > > Panobinostat

>

> >

>

> > >

>

> >

>

> > > Pazopanib

>

> >

>

> > > Pegaspargase

>

> >

>

> > >

>

> >

>

> > > Pembrolizumab

>

> >

>

> > >

>

> >

>

> > > Pemetrexed

>

> >

>

> > >

>

> >

>

> > > Pemigatinib

>

> >

>

> > >

>

> >

>

> > > Pentamidine

>

> >

>

> > >

>

> >

>

> > > Pentazocine

>

> >

>

> > >

>

> >

>

> > > Pentetreotide

>

> >

>

> > >

>

> >

>

> > > Pentoxifylline

>

> >

>

> > >

>

> >

>

> > > Pertuzumab

>

> >

>

> > >

>

> >

>

> > > Pimavanserin Tartrate

>

> >

>

> > >

>

> >

>

> > > Pipobroman

>

> >

>

> > >

>

> >

>

> > > Pirarubicin

>

> >

>

> > >

>

> >

>

> > > Pixantrone

>

> >

>

> > >

>

> >

>

> > > Plecanatide

>

> >

>

> > >

>

> >

>

> > > Pomalidomide

>

> >

>

> > >

>

> >

>

> > > Ponatinib

>

> >

>

> > >

>

> >

>

> > > Porfimer

>

> >

>

> > >

>

> >

>

> > > Pralatrexate

>

> >

>

> > >

>

> >

>

> > > Pralsetinib

>

> >

>

> > >

>

> >

>

> > > Racotumomab

>

> >

>

> > >

>

> >

>

> > > Raltitrexed

>

> >

>

> > >

>

> >

>

> > > Ramucirumab

>

> >

>

> > >

>

> >

>

> > > Ranimustine

>

> >

>

> > >

>

> >

>

> > > Regorafenib

>

> >

>

> > >

>

> >

>

> > > Ribociclib

>

> >

>

> > >

>

> >

>

> > > Rifaximin

>

> >

>

> > >

>

> >

>

> > > Ripretinib

>

> >

>

> > >

>

> >

>

> > > Ritonavir

>

> >

>

> > >

>

> >

>

> > > Rituximab

>

> >

>

> > >

>

> >

>

> > > Rivastigmine Tartrate

>

> >

>

> > >

>

> >

>

> > > Rizatriptan Benzoate

>

> >

>

> > >

>

> >

>

> > > Romidepsin

>

> >

>

> > >

>

> >

>

> > > Ropivacaine Hydrochloride

>

> >

>

> > >

>

> >

>

> > > Roxadustat

>

> >

>

> > >

>

> >

>

> > > Rucaparib

>

> >

>

> > >

>

> >

>

> > > Ruxolitinib

>

> >

>

> > >

>

> >

>

> > > Sacituzumab Govitecan

>

> >

>

> > >

>

> >

>

> > > Safinamide

>

> >

>

> > >

>

> >

>

> > > Samidorphan

>

> >

>

> > >

>

> >

>

> > > Saxagliptin

>

> >

>

> > >

>

> >

>

> > > Selinexor

>

> >

>

> > >

>

> >

>

> > > Selpercatinib

>

> >

>

> > >

>

> >

>

> > > Semaglutide

>

> >

>

> > >

>

> >

>

> > > Sincalide

>

> >

>

> > >

>

> >

>

> > > Siponimod Fumarate

>

> >

>

> > >

>

> >

>

> > > Sonidegib

>

> >

>

> > >

>

> >

>

> > > Sorafenib

>

> >

>

> > >

>

> >

>

> > > Sotorasib

>

> >

>

> > >

>

> >

>

> > > Sunitinib

>

> >

>

> > >

>

> >

>

> > > Tafamidis

>

> >

>

> > >

>

> >

>

> > > Tafasitamab

>

> >

>

> > >

>

> >

>

> > > Tagraxofusp

>

> >

>

> > >

>

> >

>

> > > Talazoparib

>

> >

>

> > >

>

> >

>

> > > Tamoxifen

>

> >

>

> > >

>

> >

>

> > > Tamsulosin Hcl

>

> >

>

> > >

>

> >

>

> > > Tazemetostat

>

> >

>

> > >

>

> >

>

> > > Tebentafusp

>

> >

>

> > >

>

> >

>

> > > Tegafur

>

> >

>

> > >

>

> >

>

> > > Temoporfin

>

> >

>

> > >

>

> >

>

> > > Temozolomide

>

> >

>

> > >

>

> >

>

> > > Temsirolimus

>

> >

>

> > >

>

> >

>

> > > Tepotinib

>

> >

>

> > >

>

> >

>

> > > Teriflunomide

>

> >

>

> > >

>

> >

>

> > > Terlipressin  Acetate

>

> >

>

> > >

>

> >

>

> > > Tetracosactide

>

> >

>

> > >

>

> >

>

> > > Tezacaftor

>

> >

>

> > >

>

> >

>

> > > Tigecycline

>

> >

>

> > >

>

> >

>

> > > Tivozanib

>

> >

>

> > >

>

> >

>

> > > Tolvaptan

>

> >

>

> > >

>

> >

>

> > > Trastuzumab

>

> >

>

> > >

>

> >

>

> > > Treprostinil

>

> >

>

> > >

>

> >

>

> > > Tretinoin

>

> >

>

> > >

>

> >

>

> > > Tucatinib

>

> >

>

> > >

>

> >

>

> > > Umbralisib

>

> >

>

> > >

>

> >

>

> > > Upadacitinib

>

> >

>

> > >

>

> >

>

> > > Valganciclovir Hcl

>

> >

>

> > >

>

> >

>

> > > Valrubicin

>

> >

>

> > >

>

> >

>

> > > Vandetanib

>

> >

>

> > >

>

> >

>

> > > Vemurafenib

>

> >

>

> > >

>

> >

>

> > > Vinblastine

>

> >

>

> > >

>

> >

>

> > > Vincristine

>

> >

>

> > >

>

> >

>

> > > Vindesine

>

> >

>

> > >

>

> >

>

> > > Vinflunine

>

> >

>

> > >

>

> >

>

> > > Vinorelbine

>

> >

>

> > >

>

> >

>

> > > Vorinostat

>

> >

>

> > >

>

> >

>

> > > Zanubrutinib

>

> >

>

> > >

>

> >

>

> > > Zileuton

>

> >

>

> > >

>

> >

>

> > > Zolmitriptan

>

> >

>

> > > Note  :

>

> >

>

> > >

>

> >

>

> > > ·         Products are intended only for laboratory

>

> >

>

> > > research and analytical use. They are not for human or veterinary use.

>

> >

>

> > >

>

> >

>

> > > ·          We  dont  deal  in  any

>

> >

>

> > >  controlled substances  products .

>

> >

>

> > >

>

> >

>

> > > ·          Products protected by patent in the country

>

> >

>

> > > are not offered for sale to that country. It is buyer’s responsibility to

>

> >

>

> > > comply with the rules and regulations of his/her country.

>

> >

>

> > >

>

> >

>

> > >  

>

> >

>

> > >

>

> >

>

> > > Kindly  let us know  your  interest . Euroasia’s  welcome

>

> >

>

> > >  all  inquiries  pertaining to research of any Therapeutic

>

> >

>

> > > classifications .

>

> >

>

> > >

>

> >

>

> > >  

>

> >

>

> > >

>

> >

>

> > > Warm  Regards,

>

> >

>

> > > Euroasia's

>

> >

>

> > > Kishore Chokhani

>

> >

>

> > >

>

> >

>

> >

>

> >

>

> >

>

> >

>

> >

>

> >

>

> >

>

> >

>

>

>

>

>

>

>

>

Dear Sir,
Thank you for your email Please let us know which compound you require Accordingly we will share information for it 
On Fri, 30 Dec 2022 at 10:36, Sushmita Euroasia's Group INC <[email protected]> wrote:
Dear Sir,
Thank you for your email Please let us know which compound you require Accordingly we will share information for it 
On Fri, Dec 30, 2022 at 10:03 AM Kishor Chokhani <[email protected]> wrote:

---------- Forwarded message ---------
From: Kimberly Day <[email protected]>
Date: Wed, 21 Dec 2022 at 23:51
Subject: Re: Anti-Cancer Compounds For Research
To: <[email protected]>

Hello,

can you give me an example of this? I would like to know roughly what it looks like.

Kimberly Day

CEO, MNesty, LLC

On 21/12/2022 06:22 AM,  wrote:

> Researcher,

>  

> We feel honored to introduce ourselves as one of the trading and

> sourcing companies based in India / China offering a wide range of research

> chemicals and biochemicals including novel life-science reagents, reference

> compounds and Natural compounds for laboratory and scientific use. The volume

> of our products ranges from milligrams to kilograms scale. We Offer  our

>  products to Research institutions , CRO’s , Biotech Companies  and

>  Universities all  over  the  world .

>

>  

>

> We currently are offering  below  compounds for  clinical trials

>  in  pack size of 5mg / 10mg / 20mg/ 50mg / 100mg / 200mg and

>  1000mg , bigger the  quantity the better  the  price .

>

>

>  

> Abaloparatide

>

> Abemaciclib

>

> Abiraterone

>

> Acalabrutinib

>

> Aclarubicin

>

> Afatinib

>

> Aflibercept

>

> Aldesleukin

>

> Alectinib

>

> Alemtuzumab

>

> Alitretinoin

>

> Alpelisib

>

> Altretamine

>

> Ambrisentan

>

> Amivantamab

>

> Amorolfine Hcl

>

> Amrubicin

>

> Amsacrine

>

> Anagrelide

>

> Anastrozole

>

> Apalutamide

>

> Apixaban

>

> Apremilast

>

> Argatroban Monohydrate

>

> Asciminib

>

> Atezolizumab

>

> Atosiban

>

> Avapritinib

>

> Avelumab

>

> Axitinib

>

> Azacitidine

>

> Belantamab Mafodotin

>

> Belinostat

>

> Belotecan

>

> Bendamustine

>

> Benzphetamine Hcl

>

> Betiatide

>

> Bevacizumab

>

> Bexarotene

>

> Bicalutamide

>

> Binimetinib

>

> Bivalirudin

>

> Bleomycin

>

> Blinatumomab

>

> Bortezomib

>

> Bosutinib

>

> Bremelanotide

>

> Brigatinib

>

> Brivaracetam

>

> Buprenorphine

>

> Buserelin

>

> Busulfan

>

> Butabarbital Base/Sodium

>

> Butalbital

>

> Cabazitaxel

>

> Cabozantinib

>

> Canagliflozin

>

> Candesartan Cilexetil

>

> Capecitabine

>

> Capmatinib

>

> Carboplatin

>

> Carfilzomib

>

> Cariprazine Hcl

>

> Carmofur

>

> Carmustine

>

> Cemiplimab

>

> Ceritinib

>

> Cetuximab

>

> Cilastatin Sodium

>

> Cilazapril

>

> Cisplatin

>

> Cladribine

>

> Cobimetinib

>

> Colesevelam

>

> Copanlisib

>

> Crizotinib

>

> Cytarabine

>

> Dabrafenib

>

> Dacarbazine

>

> Dacomitinib

>

> Dactinomycin

>

> Dalfampridine

>

> Dapagliflozin

>

> Daratumumab

>

> Darolutamide

>

> Dasatinib

>

> Daunorubicin

>

> Decitabine

>

> Deferasirox

>

> Deferiprone

>

> Degarelix

>

> Denosumab

>

> Dexmedetomidine

>

> Dexrazoxane

>

> Diflunisal

>

> Dihydrocodeine Bitartrate

>

> Docetaxel

>

> Dofetilide

>

> Dolasetron Mesylate

>

> Dolutegravir

>

> Doripenem

>

> Dostarlimab

>

> Doxercalciferol

>

> Doxorubicin

>

> Droxidopa

>

> Durvalumab

>

> Duvelisib

>

> Edaravone

>

> Edotreotide

>

> Elagolix Sodium

>

> Elotuzumab

>

> Eluxadoline

>

> Emapalumab

>

> Empagliflozin

>

> Enasidenib

>

> Encorafenib

>

> Entrectinib

>

> Enzalutamide

>

> Epirubicin

>

> Erdafitinib

>

> Eribulin

>

> Erlotinib

>

> Ertapenem Sodium

>

> Estramustine

>

> Etelcalcetide Hcl

>

> Everolimus

>

> Exemestane

>

> Febuxostat

>

> Fedratinib

>

> Felbamate

>

> Fingolimod Hcl

>

> Flecainide Acetate

>

> Fludarabine

>

> Fluorouracil

>

> Fluoxymesterone

>

> Fluticasone Propionate

>

> Fluvastatin Sodium

>

> Fluvoxamine Maleate

>

> Foscarnet Sodium

>

> Fosphenytoin Sodium

>

> Fotemustine

>

> Fulvestrant

>

> Gefitinib

>

> Gemcitabine

>

> Gilteritinib

>

> Glasdegib

>

> Goserelin

>

> Ibandronate Sodium

>

> Ibritumomab Tiuxetan

>

> Ibrutinib

>

> Ibutilide Fumarate

>

> Icatibant Acetate

>

> Idarubicin

>

> Idelalisib

>

> Imatinib

>

> Iobenguane

>

> Ipilimumab

>

> Irbesartan

>

> Irinotecan

>

> Isatuximab

>

> Isotretinoin

>

> Ivosidenib

>

> Ixabepilone

>

> Ixazomib

>

> Lanreotide

>

> Lapatinib

>

> Larotrectinib

>

> Lercanidipine Hcl

>

> Ledipasvir

>

> Leflunomide

>

> Lenalidomide

>

> Lenvatinib

>

> Leucovorin Calcium, USP

>

> Leuprolide

>

> Levorphanol

>

> Levosimendan

>

> Levothyroxine Sodium

>

> Linaclotide

>

> Linagliptin

>

> Lomustine

>

> Loncastuximab Tesirine

>

> Lorlatinib

>

> Loteprednol Etabonate

>

> Lubiprostone

>

> Luliconazole

>

> Lumacaftor

>

> Lurasidone Hcl

>

> Lurbinectedin

>

> Margetuximab

>

> Mefloquine

>

> Melphalan

>

> Memantine

>

> Mesalamine

>

> Methamphetamine Hcl

>

> Methenamine

>

> Methotrexate

>

> Methylphenidate Base

>

> Metoclopramide HCl

>

> Midodrine

>

> Midostaurin

>

> Mifamurtide

>

> Milrinone

>

> Mitomycin

>

> Mitoxantrone

>

> Mobocertinib

>

> Mogamulizumab

>

> Mosunetuzumab

>

> Moxetumomab Pasudotox

>

> Mycophenolate Mofetil

>

> Naltrexone Hcl

>

> Naxitamab

>

> Necitumumab

>

> Nelarabine

>

> Neratinib

>

> Netarsudil

>

> Nilotinib

>

> Nilutamide

>

> Nintedanib

>

> Niraparib

>

> Nisoldipine

>

> Nivolumab

>

> Octreotide Acetate

>

> Olaparib

>

> Olaratumab

>

> Omacetaxine Mepesuccinate

>

> Oripavine

>

> Osimertinib

>

> Oxaliplatin

>

> Oxcarbazepine

>

> Oxetacaine

>

> Oxycodone Hcl

>

> Paclitaxel

>

> Padeliporfin

>

> Palbociclib

>

> Paliperidone

>

> Palonosetron HCl

>

> Pamabrom

>

> Panitumumab

>

> Panobinostat

>

> Pazopanib

> Pegaspargase

>

> Pembrolizumab

>

> Pemetrexed

>

> Pemigatinib

>

> Pentamidine

>

> Pentazocine

>

> Pentetreotide

>

> Pentoxifylline

>

> Pertuzumab

>

> Pimavanserin Tartrate

>

> Pipobroman

>

> Pirarubicin

>

> Pixantrone

>

> Plecanatide

>

> Pomalidomide

>

> Ponatinib

>

> Porfimer

>

> Pralatrexate

>

> Pralsetinib

>

> Racotumomab

>

> Raltitrexed

>

> Ramucirumab

>

> Ranimustine

>

> Regorafenib

>

> Ribociclib

>

> Rifaximin

>

> Ripretinib

>

> Ritonavir

>

> Rituximab

>

> Rivastigmine Tartrate

>

> Rizatriptan Benzoate

>

> Romidepsin

>

> Ropivacaine Hydrochloride

>

> Roxadustat

>

> Rucaparib

>

> Ruxolitinib

>

> Sacituzumab Govitecan

>

> Safinamide

>

> Samidorphan

>

> Saxagliptin

>

> Selinexor

>

> Selpercatinib

>

> Semaglutide

>

> Sincalide

>

> Siponimod Fumarate

>

> Sonidegib

>

> Sorafenib

>

> Sotorasib

>

> Sunitinib

>

> Tafamidis

>

> Tafasitamab

>

> Tagraxofusp

>

> Talazoparib

>

> Tamoxifen

>

> Tamsulosin Hcl

>

> Tazemetostat

>

> Tebentafusp

>

> Tegafur

>

> Temoporfin

>

> Temozolomide

>

> Temsirolimus

>

> Tepotinib

>

> Teriflunomide

>

> Terlipressin  Acetate

>

> Tetracosactide

>

> Tezacaftor

>

> Tigecycline

>

> Tivozanib

>

> Tolvaptan

>

> Trastuzumab

>

> Treprostinil

>

> Tretinoin

>

> Tucatinib

>

> Umbralisib

>

> Upadacitinib

>

> Valganciclovir Hcl

>

> Valrubicin

>

> Vandetanib

>

> Vemurafenib

>

> Vinblastine

>

> Vincristine

>

> Vindesine

>

> Vinflunine

>

> Vinorelbine

>

> Vorinostat

>

> Zanubrutinib

>

> Zileuton

>

> Zolmitriptan

> Note  :

>

> ·         Products are intended only for laboratory

> research and analytical use. They are not for human or veterinary use.

>

> ·          We  dont  deal  in  any

>  controlled substances  products .

>

> ·          Products protected by patent in the country

> are not offered for sale to that country. It is buyer’s responsibility to

> comply with the rules and regulations of his/her country.

>

>  

>

> Kindly  let us know  your  interest . Euroasia’s  welcome

>  all  inquiries  pertaining to research of any Therapeutic

> classifications .

>

>  

>

> Warm  Regards,

> Euroasia's

> Kishore Chokhani

>

Dear Kevin,
Thank you for your emailKindly let us know which product you are looking for & what would be budget for it So that we can check price accordinglyHope you will understand 

On Thu, Jan 12, 2023 at 4:16 PM Kishor Chokhani <[email protected]> wrote:

---------- Forwarded message ---------
From: Kevin Day <[email protected]>
Date: Thu, 12 Jan 2023 at 14:25
Subject: Re: Anti-Cancer Compounds For Research
To: <[email protected]>

Hello,

Thank you for your email! However, I don't know if this will fit in our budget. Is there anything better you could do?

Kevin Day

CEO, MNesty, LLC

On 12/01/2023 04:58 AM,  wrote:

> Dear Sir,

> Thank you for your email Please let us know which compound you require Accordingly we will share information for it 

> On Fri, 30 Dec 2022 at 10:36, Sushmita Euroasia's Group INC <[email protected]> wrote:

> Dear Sir,

> Thank you for your email Please let us know which compound you require Accordingly we will share information for it 

> On Fri, Dec 30, 2022 at 10:03 AM Kishor Chokhani <[email protected]> wrote:

>

>

> ---------- Forwarded message ---------

> From: Kimberly Day <[email protected]>

> Date: Wed, 21 Dec 2022 at 23:51

> Subject: Re: Anti-Cancer Compounds For Research

> To:  <[email protected]>

>

>

> Hello,

>

> can you give me an example of this? I would like to know roughly what it looks like.

>

>

>

> Kimberly Day

>

> CEO, MNesty, LLC

>

>

>

> On 21/12/2022 06:22 AM,  wrote:

>

> > Researcher,

>

> >  

>

> > We feel honored to introduce ourselves as one of the trading and

>

> > sourcing companies based in India / China offering a wide range of research

>

> > chemicals and biochemicals including novel life-science reagents, reference

>

> > compounds and Natural compounds for laboratory and scientific use. The volume

>

> > of our products ranges from milligrams to kilograms scale. We Offer  our

>

> >  products to Research institutions , CRO’s , Biotech Companies  and

>

> >  Universities all  over  the  world .

>

> >

>

> >  

>

> >

>

> > We currently are offering  below  compounds for  clinical trials

>

> >  in  pack size of 5mg / 10mg / 20mg/ 50mg / 100mg / 200mg and

>

> >  1000mg , bigger the  quantity the better  the  price .

>

> >

>

> >

>

> >  

>

> > Abaloparatide

>

> >

>

> > Abemaciclib

>

> >

>

> > Abiraterone

>

> >

>

> > Acalabrutinib

>

> >

>

> > Aclarubicin

>

> >

>

> > Afatinib

>

> >

>

> > Aflibercept

>

> >

>

> > Aldesleukin

>

> >

>

> > Alectinib

>

> >

>

> > Alemtuzumab

>

> >

>

> > Alitretinoin

>

> >

>

> > Alpelisib

>

> >

>

> > Altretamine

>

> >

>

> > Ambrisentan

>

> >

>

> > Amivantamab

>

> >

>

> > Amorolfine Hcl

>

> >

>

> > Amrubicin

>

> >

>

> > Amsacrine

>

> >

>

> > Anagrelide

>

> >

>

> > Anastrozole

>

> >

>

> > Apalutamide

>

> >

>

> > Apixaban

>

> >

>

> > Apremilast

>

> >

>

> > Argatroban Monohydrate

>

> >

>

> > Asciminib

>

> >

>

> > Atezolizumab

>

> >

>

> > Atosiban

>

> >

>

> > Avapritinib

>

> >

>

> > Avelumab

>

> >

>

> > Axitinib

>

> >

>

> > Azacitidine

>

> >

>

> > Belantamab Mafodotin

>

> >

>

> > Belinostat

>

> >

>

> > Belotecan

>

> >

>

> > Bendamustine

>

> >

>

> > Benzphetamine Hcl

>

> >

>

> > Betiatide

>

> >

>

> > Bevacizumab

>

> >

>

> > Bexarotene

>

> >

>

> > Bicalutamide

>

> >

>

> > Binimetinib

>

> >

>

> > Bivalirudin

>

> >

>

> > Bleomycin

>

> >

>

> > Blinatumomab

>

> >

>

> > Bortezomib

>

> >

>

> > Bosutinib

>

> >

>

> > Bremelanotide

>

> >

>

> > Brigatinib

>

> >

>

> > Brivaracetam

>

> >

>

> > Buprenorphine

>

> >

>

> > Buserelin

>

> >

>

> > Busulfan

>

> >

>

> > Butabarbital Base/Sodium

>

> >

>

> > Butalbital

>

> >

>

> > Cabazitaxel

>

> >

>

> > Cabozantinib

>

> >

>

> > Canagliflozin

>

> >

>

> > Candesartan Cilexetil

>

> >

>

> > Capecitabine

>

> >

>

> > Capmatinib

>

> >

>

> > Carboplatin

>

> >

>

> > Carfilzomib

>

> >

>

> > Cariprazine Hcl

>

> >

>

> > Carmofur

>

> >

>

> > Carmustine

>

> >

>

> > Cemiplimab

>

> >

>

> > Ceritinib

>

> >

>

> > Cetuximab

>

> >

>

> > Cilastatin Sodium

>

> >

>

> > Cilazapril

>

> >

>

> > Cisplatin

>

> >

>

> > Cladribine

>

> >

>

> > Cobimetinib

>

> >

>

> > Colesevelam

>

> >

>

> > Copanlisib

>

> >

>

> > Crizotinib

>

> >

>

> > Cytarabine

>

> >

>

> > Dabrafenib

>

> >

>

> > Dacarbazine

>

> >

>

> > Dacomitinib

>

> >

>

> > Dactinomycin

>

> >

>

> > Dalfampridine

>

> >

>

> > Dapagliflozin

>

> >

>

> > Daratumumab

>

> >

>

> > Darolutamide

>

> >

>

> > Dasatinib

>

> >

>

> > Daunorubicin

>

> >

>

> > Decitabine

>

> >

>

> > Deferasirox

>

> >

>

> > Deferiprone

>

> >

>

> > Degarelix

>

> >

>

> > Denosumab

>

> >

>

> > Dexmedetomidine

>

> >

>

> > Dexrazoxane

>

> >

>

> > Diflunisal

>

> >

>

> > Dihydrocodeine Bitartrate

>

> >

>

> > Docetaxel

>

> >

>

> > Dofetilide

>

> >

>

> > Dolasetron Mesylate

>

> >

>

> > Dolutegravir

>

> >

>

> > Doripenem

>

> >

>

> > Dostarlimab

>

> >

>

> > Doxercalciferol

>

> >

>

> > Doxorubicin

>

> >

>

> > Droxidopa

>

> >

>

> > Durvalumab

>

> >

>

> > Duvelisib

>

> >

>

> > Edaravone

>

> >

>

> > Edotreotide

>

> >

>

> > Elagolix Sodium

>

> >

>

> > Elotuzumab

>

> >

>

> > Eluxadoline

>

> >

>

> > Emapalumab

>

> >

>

> > Empagliflozin

>

> >

>

> > Enasidenib

>

> >

>

> > Encorafenib

>

> >

>

> > Entrectinib

>

> >

>

> > Enzalutamide

>

> >

>

> > Epirubicin

>

> >

>

> > Erdafitinib

>

> >

>

> > Eribulin

>

> >

>

> > Erlotinib

>

> >

>

> > Ertapenem Sodium

>

> >

>

> > Estramustine

>

> >

>

> > Etelcalcetide Hcl

>

> >

>

> > Everolimus

>

> >

>

> > Exemestane

>

> >

>

> > Febuxostat

>

> >

>

> > Fedratinib

>

> >

>

> > Felbamate

>

> >

>

> > Fingolimod Hcl

>

> >

>

> > Flecainide Acetate

>

> >

>

> > Fludarabine

>

> >

>

> > Fluorouracil

>

> >

>

> > Fluoxymesterone

>

> >

>

> > Fluticasone Propionate

>

> >

>

> > Fluvastatin Sodium

>

> >

>

> > Fluvoxamine Maleate

>

> >

>

> > Foscarnet Sodium

>

> >

>

> > Fosphenytoin Sodium

>

> >

>

> > Fotemustine

>

> >

>

> > Fulvestrant

>

> >

>

> > Gefitinib

>

> >

>

> > Gemcitabine

>

> >

>

> > Gilteritinib

>

> >

>

> > Glasdegib

>

> >

>

> > Goserelin

>

> >

>

> > Ibandronate Sodium

>

> >

>

> > Ibritumomab Tiuxetan

>

> >

>

> > Ibrutinib

>

> >

>

> > Ibutilide Fumarate

>

> >

>

> > Icatibant Acetate

>

> >

>

> > Idarubicin

>

> >

>

> > Idelalisib

>

> >

>

> > Imatinib

>

> >

>

> > Iobenguane

>

> >

>

> > Ipilimumab

>

> >

>

> > Irbesartan

>

> >

>

> > Irinotecan

>

> >

>

> > Isatuximab

>

> >

>

> > Isotretinoin

>

> >

>

> > Ivosidenib

>

> >

>

> > Ixabepilone

>

> >

>

> > Ixazomib

>

> >

>

> > Lanreotide

>

> >

>

> > Lapatinib

>

> >

>

> > Larotrectinib

>

> >

>

> > Lercanidipine Hcl

>

> >

>

> > Ledipasvir

>

> >

>

> > Leflunomide

>

> >

>

> > Lenalidomide

>

> >

>

> > Lenvatinib

>

> >

>

> > Leucovorin Calcium, USP

>

> >

>

> > Leuprolide

>

> >

>

> > Levorphanol

>

> >

>

> > Levosimendan

>

> >

>

> > Levothyroxine Sodium

>

> >

>

> > Linaclotide

>

> >

>

> > Linagliptin

>

> >

>

> > Lomustine

>

> >

>

> > Loncastuximab Tesirine

>

> >

>

> > Lorlatinib

>

> >

>

> > Loteprednol Etabonate

>

> >

>

> > Lubiprostone

>

> >

>

> > Luliconazole

>

> >

>

> > Lumacaftor

>

> >

>

> > Lurasidone Hcl

>

> >

>

> > Lurbinectedin

>

> >

>

> > Margetuximab

>

> >

>

> > Mefloquine

>

> >

>

> > Melphalan

>

> >

>

> > Memantine

>

> >

>

> > Mesalamine

>

> >

>

> > Methamphetamine Hcl

>

> >

>

> > Methenamine

>

> >

>

> > Methotrexate

>

> >

>

> > Methylphenidate Base

>

> >

>

> > Metoclopramide HCl

>

> >

>

> > Midodrine

>

> >

>

> > Midostaurin

>

> >

>

> > Mifamurtide

>

> >

>

> > Milrinone

>

> >

>

> > Mitomycin

>

> >

>

> > Mitoxantrone

>

> >

>

> > Mobocertinib

>

> >

>

> > Mogamulizumab

>

> >

>

> > Mosunetuzumab

>

> >

>

> > Moxetumomab Pasudotox

>

> >

>

> > Mycophenolate Mofetil

>

> >

>

> > Naltrexone Hcl

>

> >

>

> > Naxitamab

>

> >

>

> > Necitumumab

>

> >

>

> > Nelarabine

>

> >

>

> > Neratinib

>

> >

>

> > Netarsudil

>

> >

>

> > Nilotinib

>

> >

>

> > Nilutamide

>

> >

>

> > Nintedanib

>

> >

>

> > Niraparib

>

> >

>

> > Nisoldipine

>

> >

>

> > Nivolumab

>

> >

>

> > Octreotide Acetate

>

> >

>

> > Olaparib

>

> >

>

> > Olaratumab

>

> >

>

> > Omacetaxine Mepesuccinate

>

> >

>

> > Oripavine

>

> >

>

> > Osimertinib

>

> >

>

> > Oxaliplatin

>

> >

>

> > Oxcarbazepine

>

> >

>

> > Oxetacaine

>

> >

>

> > Oxycodone Hcl

>

> >

>

> > Paclitaxel

>

> >

>

> > Padeliporfin

>

> >

>

> > Palbociclib

>

> >

>

> > Paliperidone

>

> >

>

> > Palonosetron HCl

>

> >

>

> > Pamabrom

>

> >

>

> > Panitumumab

>

> >

>

> > Panobinostat

>

> >

>

> > Pazopanib

>

> > Pegaspargase

>

> >

>

> > Pembrolizumab

>

> >

>

> > Pemetrexed

>

> >

>

> > Pemigatinib

>

> >

>

> > Pentamidine

>

> >

>

> > Pentazocine

>

> >

>

> > Pentetreotide

>

> >

>

> > Pentoxifylline

>

> >

>

> > Pertuzumab

>

> >

>

> > Pimavanserin Tartrate

>

> >

>

> > Pipobroman

>

> >

>

> > Pirarubicin

>

> >

>

> > Pixantrone

>

> >

>

> > Plecanatide

>

> >

>

> > Pomalidomide

>

> >

>

> > Ponatinib

>

> >

>

> > Porfimer

>

> >

>

> > Pralatrexate

>

> >

>

> > Pralsetinib

>

> >

>

> > Racotumomab

>

> >

>

> > Raltitrexed

>

> >

>

> > Ramucirumab

>

> >

>

> > Ranimustine

>

> >

>

> > Regorafenib

>

> >

>

> > Ribociclib

>

> >

>

> > Rifaximin

>

> >

>

> > Ripretinib

>

> >

>

> > Ritonavir

>

> >

>

> > Rituximab

>

> >

>

> > Rivastigmine Tartrate

>

> >

>

> > Rizatriptan Benzoate

>

> >

>

> > Romidepsin

>

> >

>

> > Ropivacaine Hydrochloride

>

> >

>

> > Roxadustat

>

> >

>

> > Rucaparib

>

> >

>

> > Ruxolitinib

>

> >

>

> > Sacituzumab Govitecan

>

> >

>

> > Safinamide

>

> >

>

> > Samidorphan

>

> >

>

> > Saxagliptin

>

> >

>

> > Selinexor

>

> >

>

> > Selpercatinib

>

> >

>

> > Semaglutide

>

> >

>

> > Sincalide

>

> >

>

> > Siponimod Fumarate

>

> >

>

> > Sonidegib

>

> >

>

> > Sorafenib

>

> >

>

> > Sotorasib

>

> >

>

> > Sunitinib

>

> >

>

> > Tafamidis

>

> >

>

> > Tafasitamab

>

> >

>

> > Tagraxofusp

>

> >

>

> > Talazoparib

>

> >

>

> > Tamoxifen

>

> >

>

> > Tamsulosin Hcl

>

> >

>

> > Tazemetostat

>

> >

>

> > Tebentafusp

>

> >

>

> > Tegafur

>

> >

>

> > Temoporfin

>

> >

>

> > Temozolomide

>

> >

>

> > Temsirolimus

>

> >

>

> > Tepotinib

>

> >

>

> > Teriflunomide

>

> >

>

> > Terlipressin  Acetate

>

> >

>

> > Tetracosactide

>

> >

>

> > Tezacaftor

>

> >

>

> > Tigecycline

>

> >

>

> > Tivozanib

>

> >

>

> > Tolvaptan

>

> >

>

> > Trastuzumab

>

> >

>

> > Treprostinil

>

> >

>

> > Tretinoin

>

> >

>

> > Tucatinib

>

> >

>

> > Umbralisib

>

> >

>

> > Upadacitinib

>

> >

>

> > Valganciclovir Hcl

>

> >

>

> > Valrubicin

>

> >

>

> > Vandetanib

>

> >

>

> > Vemurafenib

>

> >

>

> > Vinblastine

>

> >

>

> > Vincristine

>

> >

>

> > Vindesine

>

> >

>

> > Vinflunine

>

> >

>

> > Vinorelbine

>

> >

>

> > Vorinostat

>

> >

>

> > Zanubrutinib

>

> >

>

> > Zileuton

>

> >

>

> > Zolmitriptan

>

> > Note  :

>

> >

>

> > ·         Products are intended only for laboratory

>

> > research and analytical use. They are not for human or veterinary use.

>

> >

>

> > ·          We  dont  deal  in  any

>

> >  controlled substances  products .

>

> >

>

> > ·          Products protected by patent in the country

>

> > are not offered for sale to that country. It is buyer’s responsibility to

>

> > comply with the rules and regulations of his/her country.

>

> >

>

> >  

>

> >

>

> > Kindly  let us know  your  interest . Euroasia’s  welcome

>

> >  all  inquiries  pertaining to research of any Therapeutic

>

> > classifications .

>

> >

>

> >  

>

> >

>

> > Warm  Regards,

>

> > Euroasia's

>

> > Kishore Chokhani

>

> >

>

>

>

>

>

>

>

>

>

>